University of Massachusetts Amherst

ScholarWorks@UMass Amherst
Doctoral Dissertations

Dissertations and Theses

June 2022

The Influence of Flow Mechanotransduction on Endothelial Cells
in the Lymphatic Valve Sinus
Joshua Daniel Hall
University of Massachusetts Amherst

Follow this and additional works at: https://scholarworks.umass.edu/dissertations_2
Part of the Biomechanical Engineering Commons, and the Molecular, Cellular, and Tissue Engineering
Commons

Recommended Citation
Hall, Joshua Daniel, "The Influence of Flow Mechanotransduction on Endothelial Cells in the Lymphatic
Valve Sinus" (2022). Doctoral Dissertations. 2528.
https://doi.org/10.7275/28440260 https://scholarworks.umass.edu/dissertations_2/2528

This Open Access Dissertation is brought to you for free and open access by the Dissertations and Theses at
ScholarWorks@UMass Amherst. It has been accepted for inclusion in Doctoral Dissertations by an authorized
administrator of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.

The Influence of Flow Mechanotransduction on Endothelial Cells in the
Lymphatic Valve Sinus

A Dissertation Presented
by
Joshua Hall

Submitted to the Graduate School of the
University of Massachusetts Amherst in partial fulfillment
of the requirements for the degree of
DOCTOR OF PHILOSOPHY
May 2022
MECHANICAL ENGINEERING

© Copyright by Joshua Hall 2022
All Rights Reserved

DocuSign Envelope ID: E873C420-4555-4207-B475-B501A06C995D
6D8CBABF-A0E5-4AB6-B629-667997DBB115

The Influence of Flow Mechanotransduction on Endothelial Cells in the
Lymphatic Valve Sinus

A Dissertation Presented
by
Joshua Hall

Approved as to style and content by:

___________________________________
Juan Jiménez, Adviser

___________________________________
Shelly Peyton, Member

___________________________________
Yubing Sun, Member

____________________________________________

Sundar Krishnamurty, Department Chair
Mechanical and Industrial Engineering

ABSTRACT
The Influence of Flow Mechanotransduction on Endothelial Cells in the
Lymphatic Valve Sinus
May 2022
JOSHUA HALL
B.S., WORCESTER POLYTECHNIC INSTITUTE
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Juan Jiménez

Fluid flow in the cardiovascular and lymphatic systems influences the phenotype
of endothelial cells that line the interior to the vessel via mechanotransduction. Geometric
features in a vessel such as curvature, bifurcation, and valves promote heterogeneous
fluid flow profiles, inducing a heterogeneous endothelial phenotype within a vessel
region. Certain flow conditions are associated with vascular dysfunction, and diseases
such as atherosclerosis preferentially develop in areas of flow disturbance. Lymphatic
vessels are highly analogous to blood vessels, although lymphatic flow characteristics
and its effect on lymphatic endothelial cells (LECs) via mechanotransduction have been
comparatively less examined. The most significant geometric features that influence fluid
flow in lymphatic vessels are bi-leaflet valves present in each lymphangion. In the
current study, fluid flow was characterized in murine lymphatic collecting vessels using

iv

fluorescent microparticles to examine the phenotypic difference of LECs exposed to
physiological flow conditions in vitro. Fluid flow adjacent to the valve sinus was
virtually static, while the wall of the midlymphangion experienced net-antegrade pulsatile
flow with a small degree of retrograde flow. LECs were exposed to the midlymphangion
flow waveform in a parallel plate flow chamber system and compared to cells cultured in
static conditions. LECs exposed to static conditions demonstrated relatively increased
expression of cell adhesion molecules via mRNA and protein quantification and
leukocyte attracting chemokines via mRNA quantification. The increased expression of
cell adhesion molecules and leukocyte attracting chemokines suggests that LECs in the
sinus may adopt an inflammatory phenotype. Lymphedema is a notable condition that
may result from valvular dysfunction and can significantly alter fluid flow and likely
cause phenotypic changes in LECs via mechanotransduction. Characterization of the flow
field in a vessel affected by lymphedema in a CLEC2-deficient mouse was found to be
quasi-steady with loss of pulsatility. Lymphedema is characterized by changes in
pressure, which independently influences endothelial cells (ECs). LECs were exposed in
vitro to pulsatile or steady static pressure conditions without flow. Pulsatile and steady
pressure chambers were constructed to emulate normal lymphatic pressure and
lymphedema-like pressure waveforms, respectively. The effects of exposing LECs to
steady versus pulsatile pressure of similar mean values have not previously been
examined. This study demonstrated that LECs showed increased intercellular gap
formation when exposed to steady pressure and steady flow, but not pulsatile pressure
and pulsatile flow of similar mean values. Increased endothelial permeability in a
lymphedema afflicted vessel could potentially promote lymph and antigen leakage,
exacerbating the already impaired lymph transport, impairing the adaptive immune
response, and inducing inflammation in the local interstitial tissue.
v
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Chapter

1.) Introduction
1.1) Lymphatic System Function

The lymphatic system is part of the circulatory system that performs several
essential functions such as removing interstitial fluid from tissues, absorbing and
transporting lipids from the digestive system, and trafficking immune cells (Figure 1) 1.
Lymphatic vessels are lined with lymphatic endothelial cells (LECs). The lymphatic
system is composed of thin-walled lymphatic capillaries that drain extravasated
interstitial fluid from most organs to the thoracic duct, which is then returned to the
cardiovascular system2. Lymph, the fluid that circulates through the lymphatic system, is
milky white and protein-rich. It is similar in composition to blood plasma, which it is
primarily derived from. Lymph is transported through lymph nodes, where it is cleaned
by lymphocytes before returning to the bloodstream via the left subclavian vein. Lymph
also transports bacteria and viral particles, which are killed in the lymph nodes. Dietary
fats are absorbed via lymphatic capillaries known as lacteals in the villi of the small
intestines. During digestion, fats are emulsified by bile and hydrolyzed by

1
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lipase, and converted into a mixture of fatty acids and glycerides. These are then passed
from the intestinal lumen into enterocytes. The lipids are then re-esterified to form
triglycerides. Chylomicrons are formed by combining the triglyceride with cholesterol
ester, phospholipids, and apolipoprotein B48. Chyle is a milky substance that is
composed of chylomicrons that have passed into the lacteals. Lacteals then merge to form
larger lymphatic vessels that deposit chyle in the thoracic duct where lymph enters the
bloodstream at the subclavian vein.

Figure 1: Structural and molecular features of lymphatic vessels. Blind-ended lymphatic capillaries remove fluid and
immune cells from the interstitial space. Capillary LECs (capLECs) harbour button-like intercellular junctions and
discontinuous basement membrane (BM). Pre-collecting and collecting vessels efficiently transport lymph towards
the draining lymph node due to zipper-like LEC junctions, continuous basement membrane, and intraluminal valves.
Contractile smooth muscle cells surround collecting LVs. The selected molecular markers of capLECs, collecting
(collLECs) and valve LECs (vLECs) are shown. From the draining lymph node (LN) the lymph is transported to the
next LNs until it reaches the blood circulation. From Ref 1.

1.2) Lymphatic System Anatomy

2
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The lymphatic system contains several categories of conduits: capillaries, precollecting vessels, collecting vessels, lymph nodes, lymphatic trunks, and ducts. The size
of each vessel ranges from 10 µm to 2 mm in diameter. Lymph drains from capillaries to
collecting vessels, which typically travel through several clusters of lymph nodes.
Collecting vessels lead to trunks, which connect to lymphatic ducts. Lymphatic ducts
then return lymph to the bloodstream, finishing the lymphatic circuit.
Lymphatic capillaries are blind-ended vessels that uptake interstitial fluid and
particles. They are comprised of a single, typically nonfenestrated endothelial cell layer.
Despite this, they generally have a more irregular and wider lumen size than blood
capillaries and they possess an extremely attenuated cytoplasm, with the exception of the
perinuclear region. Also, unlike blood capillaries, lymphatic capillaries do not have a
basal lamina and are not encircled by pericytes. Although tight junctions and adherens
junctions are common in blood vessels, they are seen in much lower frequency in
lymphatic capillaries. While junctions in blood capillaries primarily serve to maintain
firm cell-cell adhesion to connect adjacent endothelial cells (ECs) over entire cell
boundaries, in lymphatic capillaries, they function as focal points of adhesion instead.
LECs in capillaries are also closely connected to the surrounding tissue by strands of
elastic fibers3,4. These filaments anchor the abluminal surface of the cells to connective
tissue, adhering the lymphatic endothelium to the extracellular matrix fibers. LECs in
capillaries are also characterized by numerous invaginations and cytoplasmic vesicles
that mediate transendothelial transport of molecules into the lumen5–7.
Lymphatic capillaries have unique primary valves that allow interstitial fluid to
flow into them but not out8. Primary valves are composed of ECs that form the walls of

3
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lymphatic capillaries that open inwards when interstitial fluid pressure is greater than
inside the lymphatic capillary (Figure 2). When pressure is greater inside the capillary,
the ECs adhere more closely to prevent backflow. Lymph flow in lymphatic capillaries is
primarily propulsed via extrinsic mechanisms.
After exiting the lymphatic capillaries, lymph drains into pre-collecting lymphatic
vessels. Pre-collecting vessels contain bicuspid one-way valves similar to collecting
vessels, however, unlike collecting vessels, pre-collecting valves are located at irregular
intervals. Collecting lymphatic vessels contain smooth muscle and are not tethered to the
extracellular matrix9,10. Collecting vessels contain intraluminal valves that are also
essential to regulate net antegrade flow, as lymph propulsion is irregular and is
characterized by a low flow rate. Collecting vessels are composed of functional units
between valves called lymphangions. Unlike the blood circulatory system, the lymphatic
system has no central pumping organ11. To regulate flow, mammals rely on both intrinsic
and extrinsic forces to generate lymph propulsion. The extrinsic mechanism consists of
skeletal muscle contractions that occur during skeletal muscle contractility, arterial
pulsations, venous pressure fluctuations, respiration, and peristaltic movement of the
intestine. While larger collecting vessels are also affected by extrinsic mechanisms, they
are primarily controlled by intrinsic mechanisms regulated by the contraction of smooth
muscle cells around the vessel. Smooth muscle contractions involved in lymphatic
pumping are activated by high nitric oxide concentrations, which are regulated by wall

4
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Figure 2: Lymph is propulsed via intraluminal pressure gradients (PLymph) generated by extrinsic and
intrinsic mechanisms. Interstitial hydraulic pressure (Pin) from accumulation of interstitial fluid,
extrinsic forces, and rhythmic contractions generates transmural pressure gradients (ΔPTM) across the
endothelium of lymphatic capillaries. Intrinsic contractions are driven by lymphatic muscle cell (LM)
contractions in lymphangions of post-capillary vessels. Lymphatic capillaries and valve leaflets are not
lined with smooth muscle cells.

LEC expression of eNOS12.
All lymphatic collecting vessels pass through a series of lymph nodes where
lymph is filtered of dead cells, bacteria, and foreign matter 10. Antigens are also presented
to lymphocytes in lymph nodes to mediate the adaptive immune response. Collecting
vessels situated upstream of nodes are afferent vessels, while those downstream are
efferent. Purified lymph exits nodes via efferent vessels, where it enters lymphatic trunks.
Lymphocytes present in nodes may also exit in efferent lymph during an adaptive
immune response.
Lymphatic trunks are much larger than collecting vessels, as large as 2 mm in
diameter in humans. The trunks then drain into the final branch of the lymphatic system,
the thoracic duct. The thoracic duct passes through the aortic opening of the diaphragm

5
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and drains fluid back into the bloodstream via the junction of the left jugular and
subclavian vein.

1.3) Lymphatic Valve Function

As valve function plays an important role in lymphatic vessel flow, many
lymphatic related diseases occur from valve dysfunction. Lymphatic valves are primarily
composed of two intraluminal leaflets that are each formed by two layers of LECs
separated by an extracellular matrix rich core11. Due to the importance of valve function
in lymph flow, the physiology of valves and their effect on fluid dynamics is a large area
of research interest. Ultrasound technology has elucidated the physics of venous and
lymphatic valve operation. Lymphatic valve operation has been suggested to be similar to
that of venous valves, which have been much better studied13,14. Four distinct phases
occur during the valve cycle: opening, equilibrium, closing, and closed (Figure 3)

11,15

.

When distal pressure is greater than proximal pressure, the closed leaflets open towards
the vessel wall and allow flow to travel. At peak openness during the equilibrium phase,
the cusps form a narrowing of the lumen about 35% smaller than the distal lumen. This
increases pressure and causes flow acceleration. After opening, the leaflets remain
suspended in the flowing stream and undergo self-excited oscillations that resemble the

6
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flutter of flags in the
wind. Flow separation
occurs during the
equilibrium phase at
the leading edge of the
cusp with flow
reattachment at the
wall of the sinus. At
the wall of the sinus,
the flow bifurcates into
two streams at each
valve cusp. A portion
of the flow is directed
into the sinus pocket
behind the valve cusp.
This forms a vortex

Figure 3: Phases of a lymphatic valve during fluid flow. Valves cycle
between four distinct phases during lymph transport: opening,
equilibrium, closed, and closing. Lymph pressure gradients across the
vessel drive flow. Pressure gradients on each side of valve leaflets
(Popen, Pclose) control the opening and closing of leaflets inside the
lumen and the size of the valve orifice. Black arrows represent flow
profile and direction at different parts of the lymphangion.

along the cusp prior to re-emerging in the main stream of the vessel. The closing phase
generally consists of the leaflets moving synchronously toward the center, although in
some instances due to lower Reynolds numbers, the lymphatic valves do not fully close16–
18.

During the closed phase, the valves remain closed and flow is halted.

1.4) The Influence of Mechanotransduction on Vasculature
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ECs that compose the innermost lining of vascular walls are constantly exposed to
frictional pulsatile wall shear stress (WSS), hydrostatic pressure, and cyclic stretch
induced by flowing blood or lymph (Figure 4). A growing body of evidence supports ECs
recognize and adapt to different WSS, amplitudes, and patterns via
mechanotransduction19,20. Mechanisms located in the cell membrane such as receptor

Figure 4: Blood and lymph endothelial cells are constantly exposed to fluid flow, which applies waveforms
of wall shear stress, circumferential stress, and hydrostatic pressure. These flow mediated stimuli promote an
endothelial biological response via mechanotransduction.

tyrosine kinases, G protein-coupled receptors, integrins, and glycocalyx transduce
physical stimuli into intracellular signaling, gene expression, and protein expression.
Mechanotransduction allows ECs to adapt to their environment in response to mechanical
cues. For instance, lymphangion contraction frequency is positive correlated with
transmural pressure, allowing lymphatics to adapt to higher lymph loads21,22. Under
pulsatile laminar flow, ECs have been observed to undergo cytoskeletal remodeling and
align parallel to the fluid flow23. However, endothelial mechanotransduction can be a
double-edged sword, as certain stimuli are believed to cause endothelial dysfunction and
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initiate vascular disease19. Although the effects of flow on cardiovascular development
and disease are better understood, the lymphatic system is analogous and requires WSS
mediated mechanotransduction for normal development. WSS has been established to be
necessary for the expression of genes necessary for valve development in LECs (Figure
5). LECs highly expressed the genes necessary for valve development such as Foxc2,
Cx37, Itga9, and Gata2 under pulsatile WSS, but insufficiently expressed them in static

Figure 5: Mechanotransduction mediated lymphatic valve morphogenesis. Flow regulated Foxcx2
and PROX1 regulate the expression of connexin37, which controls calcineurin/NFAT signaling.
Cx37 and calcineurin mediate the development and assembly of lymphatic valves.

conditions in vitro 24,25. Abolishing lymph flow in mice via Clec2 knockdown similarly
impaired valve development.
The WSS magnitude within lymphatics is significantly lower than that in blood
vessels26. Additionally, LECs have been reported to respond to lower WSS values than
BECs27,28. The mechanisms that allow LECs to respond to lower WSS are not well
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understood, although the LEC-specific receptor VEGFR3 has been suggested to form a
sensitive mechanosensory complex29. Mechanotransduction has also been demonstrated
to occur in bone, cartilage, and skeletal muscle, and the cellular mechanisms are largely
conserved.

1.5) Heterogeneous Endothelial Phenotype is the Result of Vessel Geometry

Although one would expect ECs in an individual’s vessels to have a generally similar
phenotype, vascular diseases have been well documented to selectively develop in specific vessel
geometries. For instance,
atherosclerosis frequently
develops adjacent to vessel
bifurcations and regions of
small radii of curvature where
blood flow separates, but rarely
develops in linear vessel
regions where blood flow does
not separate 30. ECs in arterial
sites where blood flow
separates consistently adopt a
dysfunctional phenotype and

Figure 6: Vascular geometry promotes heterogeneous flow
profiles within a vessel, inducing a heterogeneous endothelial
cell phenotype via mechanotransduction. Recirculation zones and
regions of flow separation often develop endothelial dysfunction.

are at a higher risk of developing diseases. In a uniform cylindrical vessel, the WSS,

hydrostatic pressure, and circumferential stress experienced by all ECs would be
theoretically identical. However, actual vessels contain many irregular geometries, which
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cause the endothelium to be exposed to spatially dependent heterogeneous fluid flow, and
thus express a heterogenous endothelial phenotype. When considering arterial
bifurcations and curved segments, these vascular regions experience flow separation,
which can expose the local ECs to a flow waveform characterized by low WSS and a
degree of flow reversal. ECs in straighter vessel geometries, such as the common carotid
artery, generally do not develop atherosclerosis and are exposed to a fully antegrade flow
waveform with higher mean WSS.
Considering lymphatic vessels, the recirculation zone of lymphangion is
characterized by flow separation and recirculation, a significantly different flow
condition compared to the rest of the vessel. Heterogeneous flow fields caused by
vascular geometric features have been well established to induce a differential EC
phenotype. Atherosclerosis
and chronic inflammation
have been well established to
occur in ECs adjacent to
vessel curvature and
bifurcation where flow
separation occurs (Figure 6).
One study has observed a
heterogeneous endothelial
phenotype within rat
lymphangions 12. Fluorescent
confocal microscopy was used

Figure 7: The low shear stress in the lymphangion sinus
induces an altered endothelial cell phenotype compared to
endothelial cells in the rest of the vessel. ENOS, a highly flow
sensitive endothelial gene, was previously found to be less
expressed in the sinus.
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to examine LEC expression of eNOS, a gene known to be highly flow-sensitive, within a
lymphangion. eNOS expression was found to be low in the sinus, but much higher in the
rest of the lymphangion. eNOS is a highly shear sensitive gene, suggesting that other
flow sensitive genes share a similar expression profile in the sinus. The flow conditions
in the lymphangion sinus may have a significantly altered phenotype compared to LECs
in the rest of the vessel (Figure 7).

1.6) Effects of Stimuli Pulsatility on Mechanotransduction in Endothelial Cells

Mechanotransduction mediates mRNA and protein expression of certain genes,
thus, certain physical stimuli can promote endothelial dysfunction. For instance, certain
flow waveforms may upregulate pro-inflammatory genes (such as TNF- 𝛼) or
downregulation of genes necessary for normal function31. To elucidate endothelial
function, in vitro studies emulate various physiological flow conditions to study
endothelial response. However, many in vitro studies investigating mechanotransduction
in vasculature prioritize replicating the magnitude of stimuli such as WSS rather than the
waveform. A growing body of evidence supports that a change in waveform period or
even loss of pulsatility can lead to endothelial dysfunction and clinical complications
even when the level of WSS applied is similar. Human umbilical vein endothelial cells
(HUVECs) had significantly different expression levels of EDN1, PTGIS, and SOD1
when exposed to steady flow and pulsatile flow at similar mean values 32. ECs a dramatic
difference in NF-κB expression Oftentimes, deviation from normally experienced
physiological physical stimuli in mechanosensitive cells leads to cellular dysfunction via
mechanotransduction.
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WSS pulsatility also plays a significant role in lymphatic function. The intrinsic
contractions of lymphangions are heavily mediated by the mechanical forces imposed on
lymphatic vessels22,33–35. As lymph formation can vary widely depending on external
factors such as digestion and respiration, the rate of lymphatic vessel contraction can
adapt in response to mechanical cues caused by increased lymph load36,37. Applying
steady WSS to a cannulated collecting vessel had a magnitude correlated inhibitory effect
on contraction frequency38. However, this inhibition was reversed when the applied WSS
oscillated, even at similar mean WSS and controlling for hydrostatic pressure. These
results demonstrate that not only can lymphatic vessels discriminate between the
frequency of WSS, but steady WSS can lead to lymphatic dysfunction in certain cases37.
Additionally, endothelial response to stretching is also sensitive to waveform.
Differential gene expression was observed in blood endothelial cells exposed to cyclic
stretch and constant static stretch at similar mean values39. However, no study has
directly compared the response of endothelial cells to cyclic and steady hydrostatic
pressure of similar mean values.

1.7) Effects of Pulsatile Pressure Vs Steady Pressure on Mechanotransduction in
Non-Endothelial Cell Types

Like WSS, hydrostatic pressure experienced by most cells is generally pulsatile in
vivo. Accordingly, mechanosensitive cells respond differently to steady pressure than
pulsatile pressure. Non-endothelial mechanosensitive cell types have been demonstrated
to grow normally under pulsatile pressure but adopt a dysfunctional phenotype under
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steady pressure. Considering that mechanosensing is widely conserved across
mechanosensitive cell types, ECs possibly respond differently to steady pressure and
pulsatile pressure of similar mean values. Osteocytes and chondrocyte cultures, which
normally experience pulsatile pressure in vivo, responded differentially to pulsatile
pressure and steady pressure of similar mean values40,41. Osteocytes in bone culture
exposed to steady pressure initiated catabolic effects on mineral metabolism, while
exposing osteocytes to pulsatile pressure promoted anabolic effects. Supporting these
findings, a study that exposed chondrocytes to either atmospheric hydrostatic pressure,
steady pressure (4MPa), or pulsatile pressure (0.1-0.4MPa) found that steady pressure
suppressed cartilage development by substantially reducing chondrocyte expression of
collagen II, aggrecan, and sox-9. In all conditions, the column of media contributed a
small amount of hydrostatic pressure. Interestingly, not only did the pulsatile pressure
waveform promote cartilage development the most despite having the same peak pressure
magnitude as the steady pressure condition, chondrocytes exposed to atmospheric
pressure showed significantly higher cartilage development than those exposed to steady
pressure. These findings demonstrate that not only is steady pressure not a substitute for
pulsatile pressure when examining pressure mediated mechanotransduction, but steady
pressure can also induce opposite effects as pulsatile pressure even at the same
magnitude. As mechanosensing is highly conserved between mechanosensitive cell types,
these findings may have implications on ECs. Hydrostatic pressure experienced by
endothelial cells is generally physiologically pulsatile, which raises the possibility that
ECs may behave abnormally under steady pressure. Steady pressure assays are inherently
limited in emulating physiologically relevant hydrostatic pressure. Endothelial cells have
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been demonstrated to be sensitive to flow pulsatility, and flow is inherently driven by
pressure gradients. Therefore, hydrostatic pressure waveform sensing may contribute to
changes in endothelial response to various flow waveforms that are typically attributed to
shear sensing. ECs need to be exposed to steady pressure and pulsatile pressure of similar
mean values to know if ECs respond to pressure waveforms similarly to chondrocytes
and osteocytes.

1.8) Effects of Pulsatile Pressure Vs Steady Pressure on Mechanotransduction in
Endothelial Cells

Endothelial response to hydrostatic pressure has been significantly less examined
than to WSS. Of the studies that have examined the endothelial response to hydrostatic
pressure, most have neglected the influence of pulsatility, and have compared ECs
exposed to atmospheric pressure and steady hydrostatic pressure steady pressure. One
study found that HUVECs exposed to 200mmHg steady pressure had increased
permeability and increased actomyosin formation42. Another found that HUVECs
exposed to either 50mmHg or 100mmHg steady pressure had increased myosin light
chain phosphorylation and cytoskeletal contractility 43. This contractility response was
attenuated by the application of blebbistatin, a myosin II inhibitor, suggesting that
actomyosin activation is primarily mediating the contractile response. Fewer studies
have compared the effects of exposing ECs to cyclic pulsatile pressure and atmospheric
pressure. HUVECs exposed to 60/20mmHg 1Hz sinusoidal pulsatile pressure
experienced no change in permeability compared to those exposed to atmospheric
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pressure 44. In the same study, HUVECs exposed to 140/100mmHg pulsatile pressure
actually had decreased permeability when exposed to pulsatile pressure. These two
independent studies suggest that steady pressure promotes endothelial actomyosin
contractility and loss of barrier function, while pulsatile pressure promotes a normal
phenotype. However, no study has directly compared the biological effects of exposing
ECs to physiologically relevant pulsatile pressure and steady pressure of similar mean
values. Additionally, no study has examined the effects of applying hydrostatic pressure
to LECs, which may respond to lower pressure magnitudes compared to BECs as they do
to WSS.
From a clinical perspective, a change in vascular hydrostatic pressure magnitude
resulting from complications like arterial hypertension can promote endothelial
dysfunction. However, changes in vessel pressure waveform period or even total loss of
pulsatility could potentially lead to a differential endothelial response even when the
pressure magnitude is within normal parameters. Therefore, elucidating the effects of
hydrostatic pressure pulsatility on ECs has potentially translatable implications.
Lymphedema, for instance, is characterized by increased interstitial pressure. Increased
hydrostatic pressure inherently always increases lymph load, flow velocity, and
hydrostatic pressure. Several studies have measured increased intraluminal lymphatic
pressure as a result of lymphedema45. Changes in intraluminal pressure and load have
implications on lymphangion intrinsic contractility as well, affecting hydrostatic pressure
waveform.
Complicating this research, any assay that is used to emulate fluid flow exposes
cells to WSS, creating an additional variable. WSS is sensed by different cellular
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mechanisms and thus may potentially overshadow or compensate for the endothelial
response to altered hydrostatic pressure. For instance, studies have demonstrated that
elevated WSS promotes barrier function in ECs, while other studies have shown that
elevated steady pressure induces loss of barrier function. When investigating hydrostatic
pressure-mediated mechanotransduction, isolating pressure magnitude, waveform, and
WSS as separate variables is critical. Elucidating static pressure mechanotransduction
could have significant implications in treating pressure-related complications like arterial
hypertension and lymphedema.

1.9) Endothelial Barrier Function

Physical barriers are essential to separate different compartments for development
and maintenance in a multicellular organism. Barrier function between cells is primarily
achieved by junctional complexes between adjacent cells composed of cell-cell junction
proteins. Animals have four general types of cell-cell junctions: gap junctions,
desmosomes, adherens junctions, and tight junctions46. Tight junctions are the most
significant contributors of endothelial barrier function. The endothelium forms a barrier
between the vessel lumen and tissue that regulates the flow of ions, substances, and fluid
into and out of a tissue. Endothelial barrier dysfunction is characterized by increased
transendothelial flux, which is a serious problem in most vessels. Barrier dysfunction
occurs during many inflammatory conditions such as trauma, sepsis, diabetes, and
cardiovascular disease. Endothelial barrier dysfunction is generally characterized as the
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result of cell-cell junction disruption in response to inflammatory mediators such as
thrombin.

1.10) Lymphatic Collecting Vessel Permeability

Historically, collecting lymphatics were considered to be relatively impermeable
to solutes and solely functioned to transport lymph47. Findings have demonstrated that
collecting vessels are considerably permeable and suggested that regulation of collecting
vessel permeability is important to lymphatic function. Collecting vessels in rat
mesenteries were found to be similarly permeable to venules in flux of macromolecules
like albumin48. Additionally, transport of macromolecules across the collecting lymphatic
endothelium is coupled to water flux and permeability was a function of hydrostatic

Figure 8: Lymphatic endothelial hyperpermeability inhibits lymph transport and causes antigen
leakage into surrounding interstitial space.

pressure. Although physiological role and mechanisms of flux in collecting vessels need
to be further elucidated, hyperpermeability is associated with deleterious effects. Lymph
transport is impaired during increased collecting vessel permeability, as extravasated
lymph becomes interstitial fluid that must reenter lymphatic capillaries 49. As lymph
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transport is an essential role of the lymphatic system, several lymphatic functions are
impaired when transport is inhibited. Antigens and antigen presenting cell transport to
lymph nodes is impaired, weakening the adaptive immune response. Impaired transport
results in accumulation of interstitial fluid. As lymphedema is a disease characterized by
lymph accumulation, collecting vessel permeability is potentially implicated. Although
flux in collecting vessels afflicted by lymphedema has not been measured, increased
permeability would likely exacerbate the poor lymph transport that is characteristic of the
disease. In rats, increasing permeability in rat collecting vessels reduced capillary
interstitial fluid uptake, reducing lymph transport50. Additionally, increased permeability
in murine collecting vessels induced local inflammation of surrounding tissue51.
Hyperpermeability in LECs could cause antigen leakage that would impair adaptive
immunity, reduce lymph transport, and induce inflammation in local interstitial tissue
(Figure 8). Regulation of permeability in collecting vessels and its role in lymphatic
function requires further study.

1.11) Myosin Light Chain Kinase Dependent Permeability

Apart from downregulation of junction proteins, cytoskeletal tension causes
retraction at cell-cell interfaces, which causes endothelial gap formation and disrupts
barrier function. An important mechanism of endothelial hyperpermeability is increased
myosin light chain kinase (MLCK) activity, which induces cytoskeletal tension via
phosphorylation of myosin light chain (MLC)52,53. Actomyosin stress fiber formation
mediated cytoskeleton contraction causes cell membrane retraction and intercellular gap
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formation, promoting transendothelial flux (Figure 9). Conversely, myosin light chain
phosphatase (MLCP) dephosphorylates MLC, which relieves cytoskeletal tension. Either
an increase in MLCK or a decrease in MLCP activity can result in increased stress fiber
assembly and consequent hyperpermeability. MLCK mediated hyperpermeability occurs
in numerous vascular diseases such as sepsis54, trauma55, burns56, and chronic
inflammatory conditions. MLCK mediated endothelial hyperpermeability has many
consequences: alveolar flooding in lungs57, pancreatitis58, and most significantly,
atherosclerosis59. and accordingly, strategies to attenuate MLCK activity have significant
clinical potential60. Inhibitors such as ML-7 have been demonstrated to attenuate MLCK
mediated hyperpermeability in cell culture and animal models. Atherosclerosis, a disease
originating from increased LDL extravasation, can be alleviated in rats by administration
of ML-761. Interestingly, complete deletion of MLCK in mice attenuated endothelial
hyperpermeability but caused no significant impairment to vascular function62. Inhibiting
endothelial MLCK in human patients to treat vascular diseases is challenging because
MLCK is widely expressed and performs many functions in other cell types, leading to
significant side effects. Currently, no MLCK inhibitors have been approved for use in
humans, although future advances in endothelial-specific targeted drug delivery could
potentially allow these inhibitors to treat endothelial hyperpermeability without affecting
other cell types 63. More studies are needed to identify instances of MLCK mediated
endothelial hyperpermeability to elucidate the basic mechanism of vascular dysfunction
and develop therapies.
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1.12) Lymphedema

Lymphedema is a progressive and debilitating condition that is characterized by
interstitial swelling of excess fluid resulting from mechanical insufficiency of the
lymphatic system64. Lymphedema is classified as primary or secondary. Primary
lymphedema occurs as the
result of innate dysfunction in
lymphatics, such as lymphatic
agenesis or hypogenesis.
Genetics play a complex role
in primary lymphedema, and
currently, at least 23
associated genes have been
identfied65. In many cases,
defective secondary valves
are the underlying cause of
primary lymphedema66.
Secondary lymphedema is

Figure 9: a) Endothelial cells under normal myosin light chain (MLC)
phosphorylation equilibrium between myosin light chain kinase (MLCK)
and myosin light chain phosphatase (MLCP). (b) Increased MLC
phosphorylation increases endothelial contractility. The related
membrane contraction causes gap formation and decreased barrier
function.

significantly more common and results from lymphatic vessels becoming damaged or
obstructed. Secondary lymphedema may be the result of inflammatory, surgical,
iatrogenic, filarial infection, or traumatic damage. In developed countries, secondary
lymphedema is most commonly caused by the removal of or lymph nodes during cancer
treatment67. Additionally, a rapidly increasing number of obese patients have developed
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lymphedema with no other underlying causes68,69. As the obesity epidemic expands,
lymphedema cases could similarly increase, emphasizing the importance of studying the
physiological consequences of lymphedema. Currently, no studies have accurately
quantified the flowrate inside diseased lymphedema vessels. Measuring the flow rate
inside of lymphatic vessels is inherently challenging because not only due to the small
size scale of lymphatics, but also the diameter and flow velocities vary greatly within an
individual. Therefore, the vessel diameter and flow velocity must be simultaneously
measured to observe flowrate. Additionally, comparisons between vessels may be limited
due to variances. Some studies have induced edema conditions in animals and observed
increased lymph flow rates in healthy collecting vessels70–72. However, diseased
collecting vessels may behave differently in similar circumstances. The flow conditions
within lymphedema vessels need to be elucidated to examine LECs change via
mechanotransduction.

1.13) Interstitial and Endolymphatic Pressures in Lymphedema Vessels

In order for lymph to return to the venous system, lymph must overcome the
adverse pressure difference. Fluid in interstitial spaces is typically less than atmospheric
pressure and is roughly 20 cmH2O in humans73. Lymphangions overcome adverse
pressure differences via smooth muscle contractions to increase inlet pressure upstream
of the valve. Rat mesenteric lymphatic contractions failed to open the valve when
transverse pressure gradients exceeded an average of 11 cmH 2O70. A chain of
lymphangions is able to overcome greater pressure gradients, as collecting vessels are
able to sense transmural pressure and adjust contractility to compensate for the increased
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lymphatic load. In human legs, lymphangions in series were able to drive flow against
approximately 40 cmH2O pressures74. The relevant transmural lymphatic pressure values
measured in cannulated murine collecting lymphatics reached a maximum systolic
pressure ranging from 5.4 to 8.8 cmH2O75. Lymphatic pressure is highly varied at
different anatomical regions due to hydrostatic pressure. The pressure measured in the
subcutaneous lymphatics in a human leg while standing were recorded to peak at an
average of 61 cmH2O76. Lymphedema can develop when adverse pressure gradients
increase to the point when lymphatics become insufficient to drive lymph flow forward.
While the maximum pressures that collecting lymphatics can generate has been measured
in canulated lymphatic vessels, this does not necessarily mean that adverse pressure
gradients greater than this measured will result in complete lymph-stasis. Although
accumulation of interstitial fluid will occur, the resulting interstitial pressure increase will
contribute to intrinsic lymphatic pressure in vivo, thus overcoming the adverse pressure
gradient. Thus, although transmural pressure will be much greater, lymph transport will
generally still occur in lymphatic vessels that are not totally occluded. However,
interstitial pressure will be the primary driver of flow as lymphangion contractions
become less effective at higher pressures.
Lymphedema is a highly varied condition, and pressure values can vary
significantly between patients and vessel regions. Pressure is difficult to measure in vivo
due to the size scale of lymphatics and the technical limitations of measurement
techniques. A common technique used to measure endolymphatic pressure is the
application of a pressure cuff. The lymphatics of mouse tails with lymphedema have been
measured using this method. Collecting lymphatics in the tails of control mice had
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pressures of roughly 11.34 cmH2O, while mice with lymphedema had as high as 44.95
cmH2O77. However, while applying a pressure cuff is simple and commonly used, it is
less accurate than more sophisticated methods.
Pressures in human lymphatic micro-vessels have been measured in patients with
varying stages of lymphedema using fluorescent microlymphography78. In healthy
individuals, interstitial pressure was an average of 0.88cmH 2O, while it rose to 9.78
cmH2O in individuals with advanced lymphedema. Healthy individuals had an
endolymphatic pressure of 5.69 cmH2O. Micro-vessels with early-stage lymphedema had
endolymphatic pressures of roughly 11.14 cmH2O. Endolymphatic pressures in microvessels measured in instances of moderate lymphedema were approximately 13.64
cmH2O. The highest pressure in patients with severe lymphedema, characterized by
incompressible fluid interstitial fluid buildup, had endolymphatic pressures of
approximately 14.95 cmH2O.
In cases of secondary lymphedema, some studies have measured endolymphatic
pressure via lymphatic congestion lymphoscintigraphy. As secondary lymphedema is
most common in breast cancer patients after lymph node dissection, examining lymphatic
pressure in this context is highly relevant to clinical medicine. Women without
lymphedema had upper lymph endolymphatic pressures of roughly 31.26 cmH2O79.
Women that developed secondary lymphedema had pressures of approximately 54.38
cmH2O in the same region.
Endolymphatic pressure values measured in human patients are still limited due to
the technical challenges of ethically obtaining accurate measurements in lymphatic
vessels of living patients. Additionally, the mechanics of the lymphatic system has been
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significantly less examined than the cardiovascular system. Furthermore, as most studies
measure lymphatic flow in the context of sedated and stationary animals and cannulated
vessels, the contributions of extrinsic muscle contractions are not involved. Lymph flow
is a complex and dynamic process that is driven by many mechanisms. Thus, obtaining
accurate physiologically relevant flow and pressure waveforms is inherently challenging.
Nonetheless, as medical imaging and flow quantification techniques improve, the
mechanics of fluid flow in lymphatics can be characterized in greater detail to better
understand the function of the lymphatic system and study implications of lymphedema
in vitro.

1.14) Crosstalk Between Lymphatic Endothelial Cells and Leukocytes or
Circulating Tumor Cells

The mechanism of tumor cell extravasation via the endothelium is very similar to
80

the mechanism of leukocyte extravasation . Circulating tumor cells initially bind to cell
adhesion molecules on the endothelium such as P-selectin, CD44, or E-selectin with
ligands present on the surface of the tumor cell to initiate the rolling phase

81,82

. Next, the

circulating tumor cell is brought to a complete stop at the adhesion step by cell adhesion
molecules such as VCAM-1 on the endothelium binding to ligands on circulating tumor
cells. However, a major difference between leukocyte diapedesis is that tumor cells
83

damage the endothelium when passing through .
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Circulating tumor cells (CTCs) that successfully extravasate and form a metastatic
lesion in a distant site are disseminating tumor cells (DTCs), although very few CTCs
become DTCs. One study found that a mere 0.02% of injected CTCs became DTCs84.
The reason certain CTCs become DTCs remains incompletely understood. Traditionally,
lymphatic vessels were believed to play a passive role in cancer metastasis, and that an
increased number and size of peritumoral lymphatic vessels might allow increased cancer
cell intravasation. However, an increasing body of evidence suggests that crosstalk
between both CTCs and LECs can promote a pro-metastatic microenvironment necessary
for CTC extravasation, survival, and proliferation (Figure 10). Organ-specific metastasis
has been well documented in several cancer types that metastasize via the lymphatic
system85,86. Breast cancers and melanomas have been observed to metastasize at distant
lymph nodes, bone marrow, lung, and liver sites, despite that these regions are distant
from the primary tumor site, no direct vascular routes are present, and metastases in other
en route tissues are rare87–89. Targeted metastasis is a complex process that is dependent
on both the phenotype of the involved CTCs and LECs. Similar to an inflammation
response, the lymphatic endothelium must be primed for diapedesis. CTCs bind to LECs
that highly express cell adhesion molecules such as LYVE1, VCAM-1, and certain
integrins. CTCs, like leukocytes, are also influenced by endothelial-secreted cytokines
that promote adhesion and diapedesis. LECs have been observed to secrete CCL21,
CXCL12, and CCL27, which are significant mediators in CTC extravasation

90,91

. CTCs

that express cytokine receptors have increased lymphatic metastatic potential. For
instance, in mice, CCR7+ breast cancer and melanoma cells metastasize to lymph nodes
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at a significantly higher rate than CCR7- CTCs

86,92

. This suggests that CCR7 specific

cytokines natively accumulate in lymph nodes, providing a suitable microenvironment
for certain cancer types. Tumor cells may also secrete growth factors received by LECs
that cultivate a prometastatic
microenvironment. For
instance, tumor cells
expressed VEGF-C,
which binds to LEC
expressed VEGFR-3
and increases pumping
and lymph flow. The
increased lymph
flowrate increases
VEGFR-3 expression,

Figure 10: Endothelial cells engage in crosstalk with cancer cells and
leukocytes that promotes extravasation. Endothelial crosstalk is
complex and implicates many genes and molecules. Chemokines and
adhesion molecules are significant mediators of extravasation via
inflammation and cancer metastasis.

which is known to be
flow regulated, causing a positive feedback loop.
The mechanisms that certain lymphatics become pro-metastatic need to be further
investigated. Chronic inflammation of tissue is associated with increased metastasis
because inflammation induces upregulation of metastatic mediators like chemokines and
adhesion molecules in LECs and lymphangiogenesis in draining lymph nodes93.
However, certain LECs may have a pro-metastatic phenotype during healthy function,
leading to region-specific metastasis. Although the mechanisms that result in pro-
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metastatic niches are likely complex, evidence suggests that mechanotransduction is a
contributing factor. The significance of WSS in CTC metastasis is becoming increasingly
recognized, although it has been primarily investigated in blood vessels 94. Some evidence
suggests that WSS may be playing an important role in lymphatic metastasis. CCL21, a
chemokine that attracts CXCR4+ and CCR7+ CTCs, is upregulated by the lymphatic
95

endothelium in response to increased lymphatic flow .

1.15) In-Transit Metastasis
Metastatic circulating tumor cells (CTCs) in the lymphatic system typically
extravasate in the lymph nodes or ultimately the cardiovascular endothelium. Thus, the
majority of studies
examining lymphatic
metastases have
focused on lymph
node metastases.
However, metastatic
tumors referred to as
in-transit metastases
(ITMs) have been
recently found to
develop in lymphatic
vessels between the

Figure 11: (a) Lymphatic metastases are conventionally thought to occur
when circulating tumor cells from a primary tumor metastasize in the
sentinel lymph node and subsequently the secondary lymph nodes. (b) Intransit metastases occur when circulating tumor cells that metastasize in
lymphatic vessels between the primary tumor and lymph nodes.

primary tumor and
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the draining lymph node (Figure 11)96. ITMs are a serious complication because dormant
CTCs can form ITMs after a primary tumor and draining lymph nodes have been
removed 97. Melanoma is the most common originator of ITMs, but carcinomas have also
been found to form ITMs in certain cases98,99. These cancer types have all demonstrated a
high degree of organ-specific metastatic potential and engage in crosstalk with LECs.
The presence of such metastases has suggested that the lymphatic endothelium
potentially provides a protective microenvironment for tumor cell survival, particularly
CTCs that express a stem cell-like phenotype. One study found that CXCR4+ melanoma
cells, that also express the CD133 stem cell marker, were in proximity to CXCL12producing lymphatic vessels in the metastatic lymph nodes and lungs

100

. This study also

found that CXCR4/CD133+ cells had higher metastatic activity than CXCR4-/CD133+
cells. The reasons why certain lymphatic vessels secrete higher concentrations of CTC
attracting chemokines is not fully understood. As CTC-LEC crosstalk appears to play a
significant role in ITM formation, studies need to elucidate the microenvironment in
draining lymphatic vessels. Additionally, the potential role of mechanotransduction in
cultivating a pro-metastatic niche in lymph vessels needs to be examined.

1.16) Influence of Lymphedema on Cancer Metastasis

Patients who undergo axillary lymph node dissection for breast cancer have
roughly a 14% chance of developing lymphedema101. Additionally, lymphedema has
been positively associated with the development of certain rare cancer types, such as
Stewart-Treves and Kaposi’s syndrome, that do not develop in healthy lymphatics 102,103.
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Rare cancers like Stewart-Treves are viewed as exotic and generally only examined in the
context of novel case studies. Roughly 0.07-0.45% of patients with lymphedema develop
Stewart-Treves after five years post lymph node dissection104. Thus, the chance of
developing a lymphedema-specific rare cancer is generally considered to be trivial and
not a significant complication of lymphedema. However, while these types of
lymphedema-specific rare cancers have been proven to develop independently of a
patient’s primary cancer, lymphedema likely also affects the chance of all cancer
metastasis recurrence. As most instances of lymphedema result from cancer intervention,
the contribution of lymphedema to cancer recurrence is difficult to determine, and
elucidating the relationship between lymphedema and cancer metastasis has received
little attention.
The longstanding presumption has been that the immunocompromising effects of
lymphedema promote a permissive microenvironment for metastatic tumor development.
A 2018 study demonstrated that mice with induced lymphedema developed cancer
metastases at a greater rate than control mice105. Furthermore, immunodeficient mice
showed no difference in metastasis development regardless of the presence of
lymphedema, demonstrating that immunocompromise is likely the primary mechanism of
lymphedema that promotes cancer metastases. Statistical examination of the rate of
cancer metastasis in lymph node dissection patients who develop lymphedema compared
to those who do not would provide crucial insight on this phenomenon. However, no
longitudinal study to date has examined the rate of cancer metastasis development in
patients with lymphedema compared to patients with normally functioning lymphatics.
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Although no clinical studies have directly compared cancer recurrence in patients
who develop lymphedema and those who do not, some researchers have examined if the
manual treatment of lymphedema promotes metastasis. Some concern exists that physical
agitation from manual massage of edematous tissue may both increase the dissemination
of circulating tumor cells into lymph and the increased lymph transport will deliver
metastatic tumor cells to downstream lymph nodes at a higher rate. One study examined
the rate of metastasis in patients post lymph node dissection who either developed no
lymphedema or who developed lymphedema and were treated by the manual lymphatic
drainage technique (MLD)106. This study found no difference between cancer recurrence
in either group. Unfortunately, while this study did not include a cohort of patients with
untreated lymphedema, the results potentially support the notion that
immunocompromise via lymphostasis is the driving mechanism of increased metastasis.
MLD may have attenuated adaptive immunity via rescuing lymph transport, preventing a
potential increase in metastasis. Hopefully, future clinical cohorts can definitively answer
this question. If confirmed, techniques to promote lymphatic drainage may be viewed as
essential therapies to reduce cancer recurrence.

1.17) Potential Mechanosensitive Gene Targets that Promote Lymphatic Cancer
Metastasis

Stewart-Treves syndrome the most notable rare cancer that develops resulting
from lymphostasis is characterized as the development of angiosarcomas occurring in
chronic lymphedema107–109. While Stewart-Treves was initially understood to occur in
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patients having undergone mastectomy as the result of axillary lymph node dissection,
the high rate of angiosarcoma occurrence in cases of lymphedema unassociated with
breast cancer has demonstrated that lymph stasis is the cause of angiosarcoma
development rather than the primary breast cancer. Stewart-Treves may develop in
patients with long-standing lymphedema that is either primary or secondary. However, it
is most often observed in breast cancer patients with secondary lymphedema after lymph
node dissection. Additionally, several malignant tumor types are more likely to develop
in edematous limbs, such as Kaposi’s sarcoma, squamous cell carcinoma, malignant
lymphoma, and melanoma 110,111.
The relationship between lymphedema and lymphatic cancer metastasis is
complex. Immune-dysfunction as a consequence of lymphedema is suspected to be a
significant contributor to increased lymphedema metastases 107,112. Due to impaired lymph
transport, immune surveillance of cancer cells is disrupted due to reduced trafficking of
immunocompetent cells.
In certain instances, cancer development may directly cause lymphedema via
tumor infiltration or compression of lymphatic vessels, referred to as malignant
lymphedema113. Malignant lymphedema generally occurs in individuals with advanced or
metastatic cancer, and the resulting lymphedema progression is rapid 114. In-transit
metastasis is also enhanced in lymphedema conditions. Mice with surgically induced
lymphedema developed more instances of melanoma in-transit metastases, in addition to
distant lymph node and lung metastases115.
As impaired lymphatic transport is the underlying cause of most clinical
complications of lymphedema, improving lymphatic transport would certainly be a
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promising potential treatment for lymphedema patients. Intuitively, pharmacological
stimulation of lymphangiogenesis has been suggested as a potential treatment of
lymphedema patients, as the development of new lymphatic vessels and increasing the
efficiency of functional lymphatics in a patient could attenuate lymph stasis 116. VEGF-C
and VEGF-D are two of the most significant regulators of lymphangiogenesis that bind to
VEGFR-3 in LECs117. Angiopoietin-1 and fibroblast growth factor 2 additionally are
important regulators of lymphatic vessel formation and growth that may be potential
therapeutic agents118,119. Human growth factor additionally has considerable
lymphangiogenic potency that has been demonstrated to improve lymphatic transport in
secondary lymphedema120.
Unfortunately, lymphangiogenic stimulation is strongly associated with increased
rates of cancer metastasis in individuals with cancer121. Lymphatic vessel development
improves circulation of tumors and metastatic dissemination of primary tumors. While
lymphangiogenic stimulation is likely strongly inadvisable in patients with comorbid
cancer and lymphedema, it could potentially reduce the risk of cancer development in
lymphedema patients without cancer due to improving immune surveillance of cancer
cells. Despite the significant negative consequences of lymphangiogenesis in cancer
patients, pro-lymphangiogenic therapies are still worth investigating and may provide
benefits that outweigh their risks in certain instances.
Addressing cancer metastasis in lymphedema patients requires understanding and
elucidation of the mechanisms and pathways of lymphedema progression that ultimately
results in lymph stasis. Patients who undergo lymph node dissection require years for
lymphedema to develop122. The general hypothesis that surgical trauma from lymph node
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removal blocks lymph flow and leads to fluid accumulation is certainly an inadequate
oversimplification of the pathophysiology of secondary lymphedema development123.
Lymphedema progression requires time and presents itself in several stages characterized
by histological changes. Initially, vessels appear identical to healthy vessels
histologically, but pathological changes occur in LECs, which is sometimes referred to as
occult lymphedema116. Subsequently, the increased endolymphatic pressure leads to
flattening of LECs and luminal dilation124. Although advanced lymphedema is
characterized by lymph stagnation, vessels with ectasis may actually have increased
flowrates to compensate for pressure increases. Advanced lymphedema is characterized
by significant hyperplasia of smooth muscle cells and collagen fibers that eventually
causes total occlusion of lymphatic vessels.
While very little is known of the mechanism that lymph node dissection leads to
smooth muscle cell and collagen hyperplasia, mechanotransduction likely plays a role. If
flow sensitive genes involved in lymphatic vessel obstruction can be identified,
attenuating therapeutics can be developed to prevent lymphedema progression and
resulting in increased metastatic consequences. As the process of intimal thickening in
lymphatic collecting vessels appears analogous to neointimal hyperplasia in blood
vessels, flow sensitive genes involved in neointimal hyperplasia should be examined in
LECs in the context of lymphedema. Neointimal hyperplasia is also known to be a highly
flow sensitive process125. For instance, platelet derived growth factor upregulation,
MAPK phosphorylation, and PI3K/Akt phosphorylation was observed in venous ECs
exposed to flow conditions present in disease prone vessels126. Additionally, the process
of neointimal hyperplasia was reduced via broad receptor tyrosine kinase inhibition.
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Glutathione S-Transferase a4 is additionally a flow sensitive gene that promotes
neointimal hyperplasia127. In addition to LECs, smooth muscle cells and fibroblasts are
highly mechanosensitive cell types128. Smooth muscle cells and fibroblasts do not
experience luminal wall shear stress but are sensitive to changes in pressure and stretch
due to elevated endolymphatic pressure. Fibroblasts mediate extracellular matrix
synthesis homeostasis in a mechanotransductive sensitive manner129. For instance, c-Fos
is a transcription factor expressed by fibroblasts that is highly upregulated in response to
cyclic strain130. Mechanical stretch additionally affects the regulation of CCN2 in
fibroblasts131. Future experiments should examine the response of fibroblasts to
mechanical conditions in early-stage lymphedema to elucidate if they are playing a role
in lymphatic collagen hyperplasia that leads to intimal thickening. While the fibroblast
response to mechanical stimuli is most often examined in the context of mechanical
stretch, their response to physiological pressure also needs to be further elucidated.
Smooth muscle cell proliferation and hyperplasia is known to be influenced by
mechanotransduction and has been studied in the context of arteries 132. mTORC1 is a
significant mechanosensitive involved in neointimal hyperplasia. As rapamycin is used as
an effective pharmaceutical inhibitor for mTORC1 in the context of arterial neointimal
hyperplasia, it could potentially be effective if the mTORC1 pathway is significant in
lymphedema smooth muscle cell proliferation133. As smooth muscle cells in arteries and
lymphatics likely have significant functional overlap, mechanosensitive genes that are
known to contribute to neointimal hyperplasia in arteries should be examined in the
context of early-stage lymphedema. If the genes and pathways involved in both processes
are determined to be primarily conserved, several pharmaceuticals approve to attenuate
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arterial neointimal hyperplasia could potentially be used to slow smooth muscle cell
proliferation in lymphedema.

2.) Lymphatic Valves Separate Lymph Flow into a Central Stream
and a Slow-Moving Peri-Valvular Milieu

2.1) Introduction

The transport of lymph throughout the lymphatic system is an incompletely
understood process and can vary significantly from one species to another 134. Interstitial
fluid is taken up by the initial lymphatics, removing cell waste and toxins from the
interstitial space. The uptake of fluid, macromolecules, and lymphocytes is aided by flaplike mini-valves formed by overlapping ECs, aquaporin-1 water channels, and highly
permeable button-like junctions in the initial lymphatics 135–138. The initial lymphatics
lack a basement membrane and are composed of a monolayer of lymphatic endothelial
cells (LECs) with long cytoplasmic projections anchored to surrounding connective tissue
139,140.

The initial lymphatics drain into precollector and subsequently collector lymphatic

vessels, with an increase in lumen size. The number of initial lymphatics draining into
precollector lymphatic vessels varies by organ. The precollector and collector lymphatic
vessels are distinguished by the presence of intraluminal valves. However, collectors also
exhibit smooth muscle cell layers to aid in the pumping of lymph. Ex vivo and
computational experiments have demonstrated that, following smooth muscle cell
contraction, lymphatic vessels distend when externally tethered or with positive
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transmural pressure 75. This vessel dilation creates a suction force that propagates to
precollector lymphatics enhancing uptake of interstitial fluid from tissues, even at
subatmospheric pressures 75. Overall, lymph is transported via a series of lymphatic
vessels that progressively become less permeable, utilizing valves to yield net antegrade
flow.
Lymph is propelled through the lymphatic vessel network by transient pressure
gradients in conjunction with intraluminal lymphatic valves, lymphatic vessel
contraction, and local tissue motion. In the absence of a central pumping organ like the
heart, pumping of lymph is highly decentralized with local motion driving the flow, and
is subject to intra- and interanimal variation. Although physiologically normal, out-ofsequence contractions of neighboring lymphangions and incomplete closure of
intraluminal valves may decrease net antegrade lymph flow and cause local retrograde
lymph flow, even in the absence of disease. While it has been observed in unaffected
individuals, lymph retrograde flow is more commonly associated with patients suffering
from lymphedema 141. Retrograde lymph flow due to lymphedema is associated with
significantly dilated lymphatic vessels, which render valves insufficient. Lymph flow in
both directions is commonly observed in dilated lymphatic vessels. The importance of
bidirectional lymph flow and its effects on lymphatic homeostasis are largely
unknown134.
While the directionality of lymph transport may be relevant in cancer metastasis,
lymphedema, immunity, and homeostasis, the mechanisms that regulate lymph transport
are incompletely understood. One of the mechanisms to propel lymph forward in
collector vessels is phasic contractions of lymphangions by the smooth muscle cells in
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the tunica media142,143. In the study by Dixon et al., even though the frequency and
amplitude of contractions were heterogenous between various mesenteric lymphatic
vessels, the relationship between vessel contraction and fluid velocity remained relatively
consistent144. Phasic contractility parameters, including amplitude and frequency, have
been quantified in vivo using near-infrared tracer imaging and have been suggested to be
dependent on WSS144,145. Although difficult to directly measure, the average lymphatic
WSS has been estimated to be 0.64 ± 0.14 dyn/cm2 in rat mesenteric lymphatic vessels
using lymphocyte velocity and vessel diameter measurements144.
Akin to ECs in the blood circulatory system, LECs respond to WSS stimuli by
upregulation and downregulation of a variety of genes. WSS has been shown to regulate
lymphatic endothelial permeability in an inversely proportional manner where greater
WSS magnitudes elicit lower permeability. This WSS effect can be abrogated via
inhibition of RAC-1146. in vivo, inducible deletion of the transcription factor Forkheadbox protein C2 (FOXC2) confers abnormal shear stress sensing by LECs resulting in
cell–cell junction defects, regression of lymphatic valves, and lymphatic vessel collapse,
leading to lymphatic dysfunction and lethality147. C-type lectin-like receptor 2 (CLEC2)
deficient mice experience disruption of lymph flow during development leading to lack
of WSS stimuli on LECs and failed development of lymphatic valves; this phenotype is
also observed with lack of FOXC2148. In contrast, exposing LECs to WSS in vitro
upregulated the expression of GATA-binding factor 2 (GATA2) and FOXC2, genes
involved in lymphatic valve development, in comparison to LECs in static conditions,
which simulates the lack of lymph flow experienced by LECs in CLEC2 deficient
mice148.
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In the circulatory system, WSS stimuli promote either an anti-inflammatory or
pro-inflammatory endothelial gene and protein expression environment that regulates
transmigration of leukocytes. For example, arterial ECs exposed to atherosusceptible
WSS waveforms shift to a pro-inflammatory phenotype characterized by upregulation of
inflammatory cytokines, leukocyte attracting chemokines, and surface adhesion
molecules that mediate cellular adhesion and extravasation149–151. Various chemokines
(IL-8, CCL2, and CXCL2) as well as cellular adhesion molecules (ICAM-1, ICAM-2,
JAM-A, and LYVE-1) are known mediators of endothelial transmigration of leukocytes
in the blood circulatory system. Akin to the circulatory system, the process of leukocyte
migration in the lymphatic system is triggered by an inflammatory response 152. The
lymphatic system is actively involved in the initiation and resolution of inflammation,
with lymphatic vessels serving as a route for lymphocytes and newly activated dendritic
cells to lymph nodes, and plays an important role in leukocyte extravasation from tissues
during resolution of inflammation 153. However, the role of lymphatic flow in the
inflammatory response of LECs has not been thoroughly examined.
Several lectins, such as E-selectin and L-selectin, are well established mediators
of leukocyte extravasation. β-galactosidase-binding galectins have been increasingly
emerging as having an immunoregulative role in ECs. The expression of galectins is
significantly altered in diseased EC phenotypes154. Increasing concentrations of LGALS8
and LGALS9 has been shown to enhance EC adhesion of T-cells, B-cells, neutrophils,
eosinophils, and monocytes with increasing concentrations 155. Whether these galectins
are sensitive to flow mediated mechanotransduction has not been determined. CD99L2 is
a glycoprotein in the CD99 family that is expressed by both leukocytes and ECs, which
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mediates leukocyte-EC adhesion via homophilic bonding156. The phosphatase 2
regulatory subunit A, α-isoform (PPP2R1A) is expressed on the surface of both LECs
and certain CTCs, such as melanoma. PPP2R1A has been demonstrated to mediate ECCTC binding via homophilic interaction157. PPP2R1A is highly expressed in both
collecting vessel LECs and tumor cells of melanoma in-transit metastases and has been
suggested to potentially be a mediator in lymphatic in-transit metastasis. Whether
PPP2R1A is mechanosensitive has not been investigated. Mannose receptor 1 (MRC1) is
one of few proteins on collecting lymphatic ECs that has been shown to mediate
leukocyte trafficking. Lymphocytes bind to LEC expressed MRC1 via CD44.
In order to elucidate the effects of WSS on lymphatic mechanobiology, it is
crucial to characterize the fluid flow environment that dictates fluid forces. To address
this need, to the best of our knowledge, the work presented herein is the first time that the
lymph flow field distal from the inguinal lymph node has been characterized in vivo. In
addition, the lymph flow field was recreated in vitro to demonstrate a WSS-dependent
pro-inflammatory LEC phenotypic change. in vivo characterization of lymphatic flow is
important to understanding a variety of diseases with affected lymph flow, and normal
drug transport in the lymphatic system. Herein, we experimentally examined how lymph
transport is affected by intraluminal bileaflet valves in vivo. Results from particle
tracking and wall contractility measurements in lymphatic vessels of mice are presented
along with in vitro LEC gene and protein WSS-dependent expression.

2.2) Methods
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2.2.1) Cell Culture

Human dermal lymphatic endothelial cells (PromoCell; Heidelberg, Germany) in
passages 2–9 were cultured in EGM-2 MV cell medium (Lonza; Basel, Switzerland).
Cells were grown to confluence on 75 × 38 mm2 borosilicate glass slides (Fisher
Scientific; Waltham, MA) coated with gelatin (Eastman; Rochester, NY) to promote
adhesion. Experiments were conducted at least 2 days after cells reaching 100%
confluence for 48 hours in a parallel plate flow chamber system (Figure 12).

2.2.2) Quantitative Reverse Transcription Polymerase Chain Reaction

Reverse transcription and quantitative real-time polymerase chain reaction was
conducted using
the CFX Connect
Real-Time
Polymerase Chain
Reaction (PCR)
Detection System
(Bio-Rad
Laboratories;
CA). Immediately
upon termination
of the in vitro
flow experiments,

Figure 12: In-vitro experimental flow set-up. A computer-operated script
relays signals to a data acquisition card modulating the peristaltic pump
with flow rate data from a flowmeter. A repeatable waveform is applied to
the PPFC and endothelial cells inside. Endothelial cells cultured on a glass
substrate are exposed to a flow waveform for 48 hours.
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total RNA was extracted from cells in static culture and from cells exposed to flow using
the RNEasy Plus Mini Kit isolation reagents (QIAGEN; Hilden, Germany). Extracted
RNA was reverse transcribed to complementary DNA using iScript gDNA Clear cDNA
Synthesis Kit (Bio-Rad Laboratories; CA) and amplified with the iQ SYBR Green
Supermix (Bio-Rad Laboratories; CA) to identify relative expression of IL-8, CCL2,
CXCL2, ICAM-1, ICAM-2, JAM-A, and LYVE-1 mRNA. Results from the in vitro
cultured LECs were normalized to those of human GAPDH. The sequences of the
primers used are shown in Table 1.

2.2.3) Western Blotting

After the 48 hour experiment of either static or lymphatic-like waveform, protein was
extracted by lysing the cells for 1 h in 10% RIPA (Cell Signaling Technology; Danvers, MA)
containing MG132 protease inhibitor (Tocris Bioscience; Bristol, UK), Halt protease inhibitor
(Life Technologies; Carlsbad, CA), and Halt phosphatase inhibitor (Life Technologies; Carlsbad,
CA) at 4 °C, centrifuging at 13,000 × g, and discarding the cell pellet. The Western blot was
conducted by separating 20 μg of protein by 10% SDS-PAGE gel (Bio-Rad Laboratories; CA)
and transferring to a PVDF membrane (Invitrogen; Carlsbad, CA). After transferring, the PVDF
membrane was incubated in a blocking buffer of PBS with 0.1% Tween-20 and 5% milk for 1 h
at room temperature and probed overnight at 4 °C with the primary and secondary antibodies
listed in Table 2. The membrane was rinsed and incubated with HRP-conjugated antibody for 1 h
at room temperature. Femto-Chemiluminescent substrate (Thermo Fisher Scientific; Waltham,
MA) was used. Digital images were acquired with the ChemiDoc Touch imager (Bio-Rad
Laboratories; CA). Densitometric band analysis was performed with Image Multi-Gauge
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Software (Fujifilm; Tokyo, Japan) and normalized to the levels of β-tubulin or β-actin. The
antibodies used are listed in Table 2.

Table 1: Primers used for qPCR.
Gene

Locus ID

Forward primer (5′–3′)

Reverse primer (5′–3′)

Fragm
ent
(bp)

ICA
M-1

NM_0002
01.1

GCGTAGGGTAAGGTTC
TTGC

GCTATTCAAACTGCC
CTGATG

128

ICA
M-2

NM_0008
73.5

ACTCAATGGTGAAGGA
CTTGC

TCCAATGCCACTTCA
CCTG

135

JAMA

NM_0169
46.1

TGACTTCAGGTTCAGA
AGAGTG

GCAAGTCGAGAGGA
AACTGT

101

LYV
E-1

NM_0066
91.1

CCATAATTCTGCATGAC ATCTGGACCACGAG
ACCTG
GCT

79

CCL2 NM_0029
82.1

GCCTCTGCACTGAGATC AGCAGCCACCTTCAT 104
TTC
TCC

CXC
L2

NM_0020
89.4

CATCGAAAAGATGCTG
AAAAATG

TTCAGGAACAGCCA
CCAATA

77

IL-8

NM_0005
84.1

CTTCACACAGAGCTGC
AGAA

GAGACAGCAGAGCA
CACAAG

143

GAP
DH

NM_0020
46.1

TGTAGTTGAGGTCAAT
GAAGGG

ACATCGCTCAGACA
CCATG

143

Table 2: Antibodies used for western blotting.
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Antibody

Host species

Vendor

Catalog #

Working
dilution

ICAM-1

Rat

Santa Cruz
Biotechnology,
Dallas, TX

sc-52553

1:500

ICAM-2

Mouse

Santa Cruz
Biotechnology,
Dallas, TX

sc-9987

1:500

JAM-A

Rabbit

Thermo Fisher
Scientific,
Waltham, MA

36-1700

1:250

LYVE-1

Rat

R&D
Biosystems,
Minneapolis,
MN

MAB2125

1:500

β-Tubulin

Mouse

Santa Cruz
Biotechnology,
Dallas, TX

166729

1:1000

Goat IgG HRP

Rabbit

Invitrogen,
Carlsbad, CA

81-1620

1:1000

Mouse IgG
HRP

Goat

Thermo Fisher
Scientific,
Waltham, MA

31430

1:1000

Rabbit IgG HRP

Goat

Thermo Fisher
Scientific,
Waltham, MA

31460

1:1000

Rat IgG HRP

Goat

Thermo Fisher
Scientific,
Waltham, MA

31470

1:1000
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2.3) Results

The flow waveforms in the valvular sinus region and mid-lymphangion region

Figure 13: (a) Ex vivo mouse lymphatic collecting vessel with fluorescent particles. (b) Pathlines
corresponding to the trajectory of fluorescent particle for 22.5 s in the lymphatic vessel. The pathlines were
used to generate representative flow condition waveforms. LECs were exposed in vitro to.

were characterized for use in in vitro experiments (Figure 13). Flow in the sinus was
found to be virtually static, while flow in the midlymphangion region was pulsatile netantegrade with a small amount retrograde flow (Figure 14). Because of the importance of
the lymphatic system in regulating an inflammatory response, the gene and protein
expressions of various chemokines (IL-8, CCL2, and CXCL2) and cellular adhesion
molecules (ICAM-1, ICAM-2, JAM-A, and LYVE-1) known to mediate endothelial
transmigration of leukocytes in the blood circulatory system were probed. Of the various
genes probed, only LYVE-1 expression has been shown in LECs to be sensitive to
lymphatic flow in vitro148. ICAM-1, IL-8, CCL2, and CXCL2 expression have been
shown to be shear sensitive in circulatory ECs, but it is unknown if LECs will respond
similarly, especially in the context of lymphatic relevant flow conditions 158–162. To our
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knowledge, expression of ICAM-2 and JAM-A have not been previously demonstrated to
be regulated by fluid shear stress in ECs originating from lymphatic or blood vessels.
The LECs
subjected to the static
VS condition for 48 h
uniformly expressed
higher mRNA
expression of cellular
adhesion molecules
ICAM-1, ICAM-2,
JAM-A, and LYVE-1
by 3.9-, 1.8-, 1.4-, and
13.5-fold,
respectively, in

Figure 14: Pulsatile ML (+ + +) or static lymphatic sinus (○ ○ ○)
representative flow conditions.

comparison to the pulsatile ML waveform (Figures 15 and 16). Similarly, the LEC
mRNA expression of transmigration relevant chemokines IL-8, CCL2, and CXCL2 was
upregulated 8.2-, 5.8-, and 4.3-fold, respectively, when exposed to the static VS
condition. LEC protein expression was also uniformly upregulated by 1.74-, 1.46-, 1.37-,
and 1.48-fold for cellular adhesion molecules ICAM-1, ICAM-2, JAM-A, and LYVE-1,
respectively, under static VS conditions. Protein measurements for secreted
transmigration relevant chemokines IL-8, CCL2, and CXCL2 was not possible given the
low protein concentration in our high cell medium volume system.
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LGALS8 and LGALS9 mRNA expression increased 1.4-fold and 3.7-fold
respectively under static conditions VS flow conditions. CD99L2, PPP2R1A, and MRC1
mRNA expression was not significantly altered between static conditions vs flow
conditions (Figure 17).

2.4) Discussion

To the best of our knowledge, this is the first study to characterize in vivo the
local flow field in the inguinal lymph node efferent lymphatic vessels of adult mice and
to connect different flow environments present in the lymphangion to a LEC proinflammatory phenotype. This study demonstrates the heterogeneous nature of lymphatic
flow and shows that valve morphology affects the directionality of lymph flow. It is the
first demonstration that the unique anatomy of lymphatic valves promotes higher flow

Figure 15: In vitro LEC ICAM-1, ICAM-2, JAM-A, LYVE-1 and (e) CCL2, CXCL2, and
IL8 mRNA expression of static lymphatic sinus condition normalized by pulsatile ML
waveform (n = 7, ANOVA, *P < 0.05, **P < 0.01, ***P < 0.001).

velocity in the center of the vessels accompanied by near zero velocity extending beyond
the near-wall region, significantly veering from the Poiseuille flow. The lymphatic valve
to lymph flow relationship also greatly influences local shear forces and transport of
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molecules with unknown consequences. Exposing LECs in vitro to the near stagnant
lymph flow conditions present in the valve sinus elicited a pro-inflammatory phenotype
in comparison to midlymphangion pulsatile flow conditions.
Lymph propulsion is regulated by local and distant elements, such as lymph
vessel contractions, skeletal muscle movement, and changes in interstitial pressure. As
the lymph intraluminal pressure increases, the circumferential stress that smooth muscle
cells experience increases, activating contractility pathways. These contractility
pathways, regulated by ion channels, are critical for the propulsion of lymph 163–165.

Figure 16: In vitro LEC ICAM-1, ICAM-2, JAM-A, LYVE-1 protein expression of static
lymphatic VS condition normalized by pulsatile ML waveform (n ≥ 4, ANOVA, *P < 0.05,
**P < 0.01).

Although maximum lymph propulsion may be expected when neighboring lymphangions
contract sequentially, our studies demonstrate that maximum propulsion is less
predictable, emphasizing the interdependence of lymph propulsion with local and distant
elements.
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Fluid shear stress is known to regulate cardiovascular EC expression of cellular
adhesion molecules that facilitate leukocyte binding, such as VCAM-1 and ICAM1160,166–168. ICAM-1 functions as
a primary receptor for LFA-1,
which is present on T cells,
monocytes, neutrophils, dendritic
cells, and macrophages. Dendritic
cell expressed Mac-1 binds to
ICAM-1 to mediate adhesion and
transmigration, while blocking of
ICAM-1 in LECs affects T cell

Figure 17: In vitro LEC LGALS9, LGALS8, PPP2R1A,
MRC1, and CD99L mRNA expression of static lymphatic
VS condition normalized by pulsatile ML waveform (n ≥ 4,
ANOVA, *P < 0.05, **P < 0.01).

adhesion, crawling, and
transmigration 169,170. Although ICAM-1 is generally considered to be the primary LFA-1
receptor in ECs, ICAM-2 also functions as a redundant receptor in lymphocyte
trafficking and plays a role in neutrophil transmigration in blood ECs171,172. Neutrophils
express both LFA-1 and Mac-1, which facilitate adhesion to the endothelium173. LFA-1
and Mac-1 are each able to adhere to either to endothelial ICAM-1 or ICAM-2 174,175. The
VS static conditions upregulated LEC ICAM-1 and ICAM-2, suggesting that LECs in the
VS region will be primed toward a pro-inflammatory state. In circulatory system ECs, the
tight junction protein JAM-A has been shown to mediate extravasation via interaction
with LFA-1 on leukocytes during diapedesis, while in LECs one study suggested that
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JAM-A plays a positive role in neutrophil transmigration176–178. Although the role of
JAM-A in lymphatic endothelial transmigration has not been thoroughly examined, we
observed that the VS static conditions upregulated LEC JAM-A expression, suggesting
that transendothelial migration may be more favorable in this region. Similar results were
observed for the major lymphatic hyaluronic acid (HA) receptor LYVE-1 that mediates
leukocyte docking via interaction with HA as a surface glycocalyx. LYVE-1 HA
interaction has been demonstrated to mediate lymphatic transendothelial migration of
both dendritic cells and macrophages 179,180. Although a LYVE-1 mediated mechanism
has yet to be reported in the lymphatic transendothelial migration of lymphocytes, HA is

Figure 18: Proposed lymphangion fluid flow model where the lymphatic valves introduce spatial fluid flow
heterogeneity. Lymph accelerates as it approaches the lymphatic valve reaching a local maximum speed near
the tip of the valve leaflets where the effective area is smallest. Lymph flow separates from the valve tips
creating recirculation zones with long particle residence times. Lymph flow reattaches in the ML region and
travels parallel to the wall. Near stagnant flow conditions persist in the VS region, especially in the vicinity of
the lymphatic valve origin. The low WSS conditions in the VS and recirculation zone serve to prime the LECs
toward a pro-inflammatory phenotype by upregulating the expression of cellular adhesion molecules ICAM-1,
ICAM-2, JAM-A, and LYVE-1 and secreted transmigration relevant chemokines IL-8, CCL2, and CXCL2.
The long particle residence time in the VS region allows leukocytes to interact with a potentially primed proinflammatory lymphatic endothelium.

also synthesized as a glycocalyx in T cells suggesting that T cells potentially engage in a
similar transmigratory mechanism 181–183.
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A potentially pro-inflammatory milieu generated by the flow field in the vicinity
of lymphatic valves was also assessed by measuring the gene expression of
transmigration relevant chemokines IL-8, CCL2, and CXCL2. IL-8 is a neutrophil
attracting chemokine that regulates transendothelial migration and has been shown to be
shear sensitive in HUVECs 184–186. The chemokine CXCL2 is another potent regulator of
neutrophil transendothelial migration and its expression in HUVECs has also been shown
to be shear sensitive 159,187. Similarly, the expression of CCL2, a chemokine that recruits
monocytes, T cells, and dendritic cells has been shown to be shear sensitive in
HUVECS188–191. The static VS flow conditions upregulated the LEC mRNA expression
of IL-8, CCL2, and CXCL2. Interestingly, both CXCL2 and IL-8 are preferentially
expressed on the luminal rather than abluminal membrane facilitating luminal recruitment
of leukocytes within the vessel192. A recent study has shown T cell extravasation into the
surrounding tissue from murine lymphatic vessels193. Although this study observed
leukocyte extravasation from initial lymphatics into the surrounding tissue, we propose
that entrapment of leukocytes in the low shear stress near-stagnant environment of the
valvular sinus along with potentially higher concentrations of secreted chemokines IL-8,
CCL2, and CXCL2 and primed LECs with upregulated expression of cellular adhesion
molecules ICAM-1, ICAM-2, JAM-A, and LYVE-1 creates conditions favorable for
transendothelial migration (Figure 18).
An increasing body of research has suggested that galectins play a role in
inflammation and leukocyte-EC adhesion154. This is the first study to our knowledge that
has reported differential galectin expression in response to fluid flow. The increased
expression of LGALS8 and LGALS9 in static conditions suggests that flow conditions in
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the lymphangion sinus may cultivate a phenotypic niche that promotes leukocyte
trafficking and inflammation in local LECs.
In the cardiovascular system, leukocytes are affected by shear stresses as low as
1–10 dyn/cm2194. Reduced shear stress induces pseudo-pod projection in leukocytes,
increasing spreading of leukocytes over ECs, and thus potential transendothelial
migration 195. Therefore, leukocytes may undergo diapedesis at a higher rate in ECs
adjacent to recirculation zones and near the valve origins in the valvular sinus, where
fluid stress is lower than other regions of the vessel. Given that LECs are also sensitive to
fluid flow148, it is possible that recirculation zones and the valvular sinus regions in the
lymphatic system are characterized by a pro-inflammatory endothelium interacting with
lymphocytes. The long particle residence time and pro-inflammatory endothelial milieu
allows for lymphocytes to interact for extended periods and may facilitate transmigration.
However, this process is not expected to be exclusive for lymphocytes, but may be
relevant to any other cell circulating in the lymphatic system, for example, circulating
tumor cells, and have potential clinical effects on in-transit metastasis196,197. The model
proposed in Figure 18 is based on the in vitro results, which suggest the presence of an
underlying pro-inflammatory lymphatic endothelial phenotype in the valvular sinus.
Future studies are needed to determine if recirculation zone flow indeed mediates
diapedesis of leukocytes or other cell types in the lymphatic system.
Stagnation points have been previously shown to affect the morphology,
migration, and density of ECs198. This may be because stagnation points create gradients
of WSS and increase the total pressures experienced by ECs198,199. Vascular sites that
coincide with stagnation points have also been shown to affect the adhesion of
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monocytes, as well as the functionality of endothelial gap junction proteins 199,200. These
combined effects may shift the lymphatic endothelium phenotype198–202.
To the best of our knowledge, this is the first time that the local fluid flow
properties of the lymphatic vessels distal from the inguinal lymph node have been
characterized in vivo and connected to an LEC pro-inflammatory phenotype in vitro via
upregulation of cellular adhesion molecules and secreted transmigration relevant
chemokines. We quantified lymph flow using particle tracking of fluorescent
microparticles in the lymphatic vessels of anesthetized mice. We compared the fluid flow
properties between a vessel with functioning bileaflet valves. We observed that normal
bileaflet valves significantly affect the flow field by generating a relatively highermomentum lymph stream at the core of the vessel compared to slow-moving recirculation
zones in the valvular sinus region. These studies have provided unique and detailed
insight into lymphatic flow, with potential applications to a variety of diseases that affect
lymph transport and drug delivery.

3.) Lymphedema-like Conditions Increase Endothelia Permeability
In Vitro
3.1) Introduction

The lymphatic system is a subsystem of the circulatory system that regulates fluid
homeostasis, immune cell trafficking, and the absorption of dietary fats 203. The initial
uptake of interstitial fluid, antigens, proteins, lipids, and inflammatory cells into

53

DocuSign Envelope ID: E873C420-4555-4207-B475-B501A06C995D
6D8CBABF-A0E5-4AB6-B629-667997DBB115

lymphatic capillaries, also called initial lymphatics, is regulated by a pressure differential
between the interstitium and the lymphatic capillaries. This transient pressure differential
further drives lymph to the precollector lymphatic vessels. Transport of lymph through
the precollectors and larger collecting lymphatic vessels is primarily propelled by the
local smooth muscle cells (SMCs) at relatively low flow rates and secondarily by skeletal
muscle contractions, respiration, and external compressions, but not by a central pump204.
Lymph flow direction in precollectors and collecting vessels is aided by sequential
contraction of SMCs and one-way bileaflet valves to maintain net antegrade flow11.
Consequently, lack of SMC contraction and valvular dysfunction can affect lymph
transport and may cause lymphedema.
Lymphedema is the accumulation of fluid in the interstitium and is generally
caused by lymph transport insufficiency as a consequence of impaired lymphatic function
205.

Lymphedema is classified into primary lymphedema, which is an inherited or

congenital condition resulting from malformation of the lymphatic system, while
secondary lymphedema is more common and results from injury or damage to the
lymphatic system. The initial stages of lymphedema are not completely understood,
although ultrasonography, histology and microscopy studies have elucidated the
physiological and structural changes of collecting vessels during the onset of the
disease124,206. Initially, the collecting lymphatic vessels transition from the normal to the
ectasis type where the vessel becomes dilated and the lumen greatly enlarged. The vessel
transitions from ectasis to the contraction type where the lymphatic vessel lumen is
partially reduced due to thickening of the smooth muscle layer and then progresses to the
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sclerosis type where the vessel lumen is narrowed accompanied by loss of elasticity and
lymphatic contractility.
The ECs that line the inner layer of blood and lymphatic vessels are exposed to
mechanical stresses, such as wall shear stress (WSS), pressure, and hoop stress, induced
by the fluid flow. In the blood circulatory system, it has been demonstrated that ECs
exposed to disturbed fluid flow experience a constantly changing WSS direction and are
more susceptible to atherosclerosis207,208. In hypertensive patients, the increase in mean
blood arterial pressure yields an increase in hoop stress and causes an increase in
endothelial reactive oxygen species, inflammation, and apoptosis 209. In vitro and in vivo,
blood ECs respond differently to pulsatile and steady blood flow, with pulsatile flow
conferring a protective phenotype clinically210–213. Patients that underwent cardioplegic
arrest for cardiac surgery and were provided pulsatile cardiopulmonary bypass blood
(CPB) flow instead of steady CPB flow experienced reduction in endothelial dysfunction
and renal replacement therapy214. Pulsatile flow increases basal release of endotheliumderived nitric oxide and decreases vascular resistance in comparison to steady blood
flow215. During the different degenerative stages of collecting lymphatic vessels in
regions of lymphedema, lymph flow rates and flow characteristics change and
consequently the mechanical stresses experienced by the LECs change. In lymphedema
patients, increased lymphatic flow rates have been observed216,217. In addition to flow
rates, pulsatility can be affected by lymphedema conditions. Flow in normal lymphatic
vessels is pulsatile, while predominantly steady under lymphedema conditions 17,76,218–220.
Although normal pulsatile lymph flow regulates LEC barrier function, it is
unclear how the loss of pulsatility that may occur during lymphedema can affect LECs
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and further exacerbate lymphedema. A possible consequence of steady lymph flow is
impairment of the lymphatic barrier function, which has been observed to increase
lymphatic permeability and may further contribute to lymphedema221. In blood ECs
barrier function is regulated by WSS with pulsatile flow downregulating permeability in
comparison to steady flow222. The disruption of blood EC barrier function and
consequent hyperpermeability is influenced by several mechanisms, including
intercellular gap formation caused by contractility of actomyosin stress fibers 52.
Disturbed flow characterized in atherosclerosis prone arteries has been shown to induce
EC hyperpermeability via cytoskeletal tension223,224. Actomyosin-driven cytoskeletal
tension is driven by F-actin stress fiber formation and phosphorylation of myosin light
chain (MLC). MLC may be single or double phosphorylated (pMLC and ppMLC) at
Ser19 or Thr18/Ser19 sites by several mediators of MLC phosphorylation, especially
myosin light chain kinase (MLCK). pMLC and ppMLC play distinct roles in blood
endothelial barrier dysfunction225. pMLC is constitutively present in the endothelial
cytosol during normal conditions but becomes localized with actin stress fibers during
inflammation. ppMLC is scarcely detected in blood ECs under normal conditions
however is observed in greater quantities during inflammation where it predominantly
localizes in peripheral stress fibers and contributes to cellular tension.

Apart from WSS, it is unclear how changes in pressure magnitude and pulsatility
could further exacerbate lymphedema. As lymphedema is often associated with changes
in transmural pressure and pulsatility, lymphedematous conditions may influence LEC
phenotype via pressure mechanotransduction219,226. In the absence of flow, steady
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pressure increases cause blood EC barrier function disruption due to MLC
phosphorylation42,227. In a separate study, blood ECs exposed to pulsatile pressure
showed decreased or no change in permeability44. Given that EC barrier function is
regulated by pressure and WSS independently, it is possible that fluid mechanics stresses
cause pMLC and ppMLC to localize to stress fibers and play a role in lymphatic barrier
function.
In the present study, we have used a CLEC2-deficient mouse, which experiences
an adverse pressure gradient that significantly affects lymph flow and drainage due to a
hemostatic defect where the thoracic duct drains into the venous system228. In the early
stages of development, the adverse pressure gradient obstructs lymph flow and affects
functional valve development, a flow dependent process148. The reduction of lymph flow
due to the adverse pressure gradient causes lymphedema. The lymphatic flow field
downstream of the inguinal lymph node of a normal and a CLEC2-deficient mouse were
characterized in vivo. The in vivo lymph flow characteristics were recreated in vitro to
address the role of normal pulsatile lymphatic flow and quasi-steady lymphedema flow
conditions on LEC barrier function. Furthermore, the effect of steady and pulsatile static
pressure was decoupled from the fluid flow to elucidate the role of static pressure on LEC
barrier function. Here, we report the differential response in phenotype and morphology
of LECs exposed to physiologically relevant steady flow, pulsatile flow, atmospheric
pressure, pulsatile pressure, and steady pressure.

3.2) Methods
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3.2.1) Cell Culture

Human dermal lymphatic endothelial cells (LECs; passage 2 – 10; PromoCell;
Heidelberg, Germany) were cultured in EGM-2 MV cell medium (Lonza; Basel,
Switzerland) at 37 °C in 5% CO2. For parallel plate flow chamber (PPFC) experiments,
cells were grown to confluence on 75 × 38 mm2 glass slides (Fisher Scientific; Waltham,
MA) coated with 0.2% gelatin (Eastman; Rochester, NY) to enable cell adhesion. For
pressure chamber experiments cells were cultured either on 6 well cell culture plates
(Trueline; USA) for mRNA and protein isolation or on #1 glass cover slips (Chemglass
Life Sciences; Vineland, NJ) coated with 0.2% gelatin for immunofluorescence. All
experiments were started at
least 48 hours after cells
reached 100% confluence.

3.2.2) Mouse Experiments

All animal

Figure 19: (a) A schematic of the mouse model highlights the ROI distal
from the inguinal lymph node, (b) which was imaged using a dissecting
epifluorescence microscope.

experiments were approved by the University of Pennsylvania Institutional Animal Care

Figure 20: Fluorescent microparticle tracking in (a) CLEC-2 deficient mouse with undeveloped valves
and (b) wild type mouse.
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and Use Committee. The Clec2–/– and Prox1-GFP BAC transgenic mice were obtained
from the Mutant Mouse Regional Resource Centers (MMRRC)229. CLEC2-deficient mice
have been previously reported to develop lymphedema and were used in the present
study228,230,231. The Prox1-GFP (normal) mouse weighed approximately 14.5 grams,
while the Clec2–/– (lymphedema) mouse weighed about 25 grams due interstitial fluid
accumulation as a consequence of lymphedema. Lymph flow was observed and
characterized in the collecting vessel downstream of the inguinal lymph node.
Fluorescent microparticles were injected into the inguinal lymph node, transported by the
lymph flow, imaged with epifluorescence microscopy, and tracked using ImageJ software
as previously described17. Flow was observed and characterized in a normal lymphatic
vessel of a wild-type (WT) mouse and a collecting vessel with lymphedema-like
conditions in a CLEC2-deficient mouse (Figures 19 and 20).

3.2.3) Steady Pressure System
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A steady pressure system was designed to emulate steady pressure in the absence
of flow (Figure 21). The pressure chamber was assembled using a commercially available
4 quart pressure cooker with three 1/16” barbed connections fitted. A PhD Ultra syringe
pump (Harvard Apparatus; Holliston, MA) with dual 60mL syringes was used to
precisely infuse or withdraw gas from the chamber to maintain constant hydrostatic

Figure 21: Schematic diagram of the computer-operated steady pressure system. The gauge pressure
within the pressure chamber was monitored via a pressure transducer. A humidifier was inserted inside
the pressure chamber. A computer-operated dual syringe pump could infuse or withdraw to compensate
for respective gas pressure decreases or increases. The solenoid valve adjacent to the pressure chamber
could close while a second solenoid valve opened to atmosphere to allow the syringe pump plungers to
reset at the median while maintaining the gauge pressure in the chamber. The syringe pump and
solenoid valves were controlled using Labview software.

pressure with high accuracy via LabVIEW software. All gas connections were joined
using 3/16” OD 73A Food Grade Santoprene tubing. To allow the pump to infuse or
withdraw from atmospheric air when full or depleted, two ET-2-12 solenoid valve
(Clippard; Cincinnati, OH) used. During standard operating conditions, solenoid 1 was
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open while solenoid 2 was closed. When the syringes were full or depleted, solenoid 1
close and solenoid 2 would open to allow for the syringes to reset to the median without
altering the
pressure in
the chamber.
The solenoid
valves were
Figure 22: Circuit diagram of solenoid valves controlled by solid state relays.

powered by a
12V power supply and toggled independently by ZGT-25DD solid state relays (Xiqi
Electrical; Wenzhou, China) (Figure 22). The pressure transducer complex was
assembled by mounting a PX26-005GV pressure transducer (Honeywell; Charlotte, NC)
to a SEK002 (Honeywell; Charlotte,
NC), which was mounted to an
Arduino Uno (Arduino; Somerville,
MA) (Figure 23). The pressure
transducer was connected to the
pressure chamber to monitor the
pressure waveform using LabVIEW
software via USB connection to a
personal computer. The LINX
software modification package was
needed to interface between the
Arduino Uno and LabVIEW using

Figure 23: Pressure transducer complex assembled
from a PX26-005GV transducer, SEK 002 sensor
evaluation kit, and an Arduino Uno.
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Makerhub. LabVIEW toggled the solid state relay to regulate the opening of the solenoid
valve via DAQ I/O device when the corresponding state was reached in response to
pressure
sensing. The
truth table and
state table for
the steady
pressure
system is show
in Tables 3 and
4 respectively.
The logic

Figure 24: Logic flowchart of the steady pressure system. Air is infused or
withdrawn when the measured pressure reaches above or below a specified
minimum or maximum value, respectively. Each instance of infusing or
withdrawing is recorded by a counter, which reflects the position of the syringe
plungers. When the count reaches -15 or 15, solenoid 1 will close and solenoid 2
will open to allow the plungers to reset to the median without affecting the pressure
in the chamber.

flowchart is shown in Figure 24. During experiments with cells, for temperature control,
the humidifier and pressure chamber was placed in an incubator to maintain the system at
37°C.
Table 3: Steady pressure system truth table.
State
5
1
2
1
4
4
4
2
3
3
3

Decimal
0
1
2
3
4
5
6
7
8
9
10

Binary
B3
0
0
0
0
0
0
0
0
1
1
1

B2
0
0
0
0
1
1
1
1
0
0
0
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B1
0
0
1
1
0
0
1
1
0
0
1

B0
0
1
1
0
0
1
0
1
0
1
0
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4
4
4
4
4

11
12
13
14
15

1
1
1
1
1

0
1
1
1
1

1
0
0
1
1

1
0
1
0
1

Table 4: Steady pressure system states.
State
1
2
3
4
5

Output
Solenoid 1
Opened
Opened
Closed
Closed
Opened

Solenoid 2
Closed
Closed
Opened
Opened
Closed

Syringe Pump
Infuse for 2,000 ms
Withdraw for 2,000 ms
Infuse for 30,000 ms
Withdraw for 30,000 ms
Hold

3.2.4) Pulsatile Pressure System
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+1
-1
+15
-15
+0
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The previously described pressure system was modified to produce pulsatile
pressure waveforms by replacing the syringe pump with a gas mixer controlled by a
solenoid valve (Figure 25). A Pegas 4000 gas mixer (Columbus Instruments; Columbus,
OH) supplied 5%CO2/95% air at a flowrate 2,800 cm3/min of through an ET-2-12
solenoid valve (Clippard; Cincinnati, OH) and into a humidifier reservoir that was joined
to the chamber. The solenoid valve was powered by 12V power supply and toggled by a

Figure 25: Schematic diagram of the computer-operated pulsatile pressure system. The gauge pressure
within the pressure chamber was monitored via a pressure transducer. A constant stream of pressurized
5%CO2/95% air was emitted from a gas mixer and passed through a humidifier. The pressure waveform
was controlled by operating an inlet solenoid valve using Labview software.

ZGT-25DD solid state relay (Xiqi Electrical; Wenzhou, China). The pressure transducer
complex was assembled by mounting a PX26-005GV pressure transducer (Honeywell;
Charlotte, NC) to a SEK002 (Honeywell; Charlotte, NC), which was mounted to an
Arduino Uno (Arduino; Somerville, MA). The pressure transducer was connected to the
pressure chamber to monitor the pressure waveform using LabVIEW software via USB
connection to a personal computer. The LINX software modification package was needed
to interface between the Arduino Uno and LabVIEW using Makerhub. LabVIEW toggled
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the solid state relay to regulate the opening of the solenoid valve via DAQ I/O device
when the corresponding state was reached in response to reading a pressure value above
or below a maximum or minimum value, respectively. A maximum pressure value of

Figure 26: Logic flowchart of the pulsatile pressure system. State 1 is reached when the pressure in the
chamber is below a certain minimum value to allow pressure to increase. State 2 is reached when the
pressure rises above a certain maximum value to allow pressure to decrease. The feedback signal
retains the most recent state while pressure is between the minimum and maximum values.

11.601 cmH2O and a minimum of 9.491 cmH2O was used. The truth table for the
pulsatile pressure system is show in Table 5. The logic flowchart is shown in Figure 26.
The humidifier reservoir was composed of a 1000mL narrow mouth Erlenmeyer flask
(Kimble Chase; Vineland, NJ) filled with 850mL DI water and sealed with a rubber
stopper housing two 1/16” barbed fittings. 60mL DI water was replenished to the
incubator every 12 hours to compensate for evaporation. During experiments with cells,
for temperature control, the humidifier and pressure chamber was placed in an incubator
to maintain the system at 37°C.
Table 5: Pulsatile pressure system truth table and state outputs.
State

Output

1
2

Solenoid 1
Opened
Closed

Decimal

Binary

0
1

B2
0
0
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1
1
2
2
1
1

Opened
Opened
Closed
Closed
Opened
Opened

2
3
4
5
6
7

0
0
1
1
1
1

1
1
0
0
1
1

0
1
0
1
0
1

3.2.5) Immunofluorescence

Fixed cells were permeabilized with 0.1% Triton X in TBS for 15 minutes. Cells
were blocked in blocking buffer prepared from 10% w/v bovine serum albumin in TBS.
The primary antibodies listed in Table 6 were diluted in blocking buffer and incubated
overnight at 4°C. Cells were washed with TBS three times for 5 minutes on an orbital
shaker. Secondary antibody was diluted in blocking buffer and incubated for one hour at
room temperature in light blocking conditions. Texas-Red phalloidin (Invitrogen;
Waltham, MA) Cells was diluted 1:40 with the secondary antibodies if applicable. Cells
were washed again with TBS three times for 5 minutes on an orbital shaker. DAPI
(Sigma-Aldrich; St. Louis, MO) was diluted 1:10,000 in blocking buffer and incubated
for 10 seconds. Cells were washed again with TBS three times for 5 minutes on an orbital
shaker. A small drop of Fluoroshield (Sigma-Aldrich; St. Louis, MO) was applied to each
sample, which was placed face down on a glass slide and permanently sealed via
application of nail polish around the perimeter. Exposure and contrast settings were
adjusted to emphasize cellular morphology and protein localization, as
immunofluorescence is not reliable for protein quantification. Western blotting was relied
upon for protein quantification. Images were taken with Metamorph software, and
Pearson correlation coefficient was determined with the ImageJ using the JACoP plugin.
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3.2.6) Endothelial Permeability Under Pressure

LECs were seeded on cell culture inserts (Corning Incorporated; Corning, NY)
with 1.0 um sized pores that were placed in 24 well cell culture plates (Trueline; USA).
Cells were grown to confluence and experiments were not run for at least 48 hours after
achieving 100% confluence. Cells were placed inside of pressure chamber and exposed to
a pressure condition for 48 hours. Each condition was replicated including 10uM of the
MLCK inhibitor ML-7 (Abcam; Waltham, MA) in the medium. After 48 hours, the
medium of the upper chamber was replaced with 150 uL of medium with 10kDa FITCDextran (TCI; Portland, OR) at 1:40 dilution. The cell culture plates were placed back in
the incubator for 1 hour to allow transendothelial flux of FITC-Dextran. After incubation,
cell culture inserts were discarded and 100uL of medium in the bottom well for each
condition was transferred to a 96 well plate in triplicate. Fluorescence measurements
were taken using a plate reader (BioTek; Winooski, VT) using excitation/emission
wavelengths of 485/530nm.

3.2.7) Western Blotting

After exposing cells to an experimental condition for 48 h experiment of either
static, normal lymphatic flow, lymphedema flow, steady pressure, or pulsatile pressure,
protein was extracted by lysing the cells for 1 h in 10% RIPA (Cell Signaling
Technology; Danvers, MA) containing MG132 protease inhibitor (Tocris Bioscience;
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Bristol, UK), Halt protease inhibitor (Life Technologies; Carlsbad, CA), and Halt
phosphatase inhibitor (Life Technologies; Carlsbad, CA) at 4 °C, centrifuging at
15,000 × g, and discarding the cell pellet. The Western blot was conducted by separating
20 μg of protein by 10% SDS-PAGE gel (Bio-Rad Laboratories; CA) and transferring to
a PVDF membrane (Invitrogen; Carlsbad, CA). After transferring, the PVDF membrane
was incubated in a blocking buffer of PBS with 0.1% Tween-20 and 5% milk for 1 h at
room temperature and probed overnight at 4 °C with the primary and secondary
antibodies listed in Table 7. The membrane was rinsed and incubated with HRPconjugated antibody for 1 hour at room temperature. Femto-Chemiluminescent substrate
(Thermo Fisher Scientific; Waltham, MA) was used. Digital images were acquired with
the ChemiDoc Touch imager (Bio-Rad Laboratories; CA). Densitometric band analysis
was performed with Image Multi-Gauge Software (Fujifilm; Tokyo, Japan) and
normalized to the levels of β-actin or β-Tubulin.

3.2.8) Quantitative Reverse Transcription Polymerase Chain Reaction

Reverse transcription and quantitative real-time polymerase chain reaction was conducted
using the CFX Connect Real-Time Polymerase Chain Reaction (PCR) Detection System
(Bio-Rad Laboratories; CA). Immediately upon termination of the in vitro flow
experiments, total RNA was extracted from cells in static culture and from cells exposed
to flow using the RNEasy Plus Mini Kit isolation reagents (QIAGEN; Hilden, Germany).
Extracted RNA was reverse transcribed to complementary DNA using iScript gDNA
Clear cDNA Synthesis Kit (Bio-Rad Laboratories; CA) and amplified with the iQ SYBR
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Green Supermix (Bio-Rad Laboratories; CA) to identify relative expression of MYH9,
MYH10, FLNB, MYL9, MYL12a, and MYL12b mRNA. Results from the target
sequences quantified from in vitro cultured lLECs were normalized to those of human
GAPDH. The sequences of the primers used are shown in Table 8.

3.3) Results

3.3.1) Flow and Pressure Waveform Generation

The pulsatile flow waveform was previously characterized in a healthy mouse
collecting vessel by our group17. The steady flow waveform was characterized in the
CLEC-2 deficient mouse used in this study. Each flow waveform was conducted in the
PPFC, and the pressure values were measured using a pressure transducer (Figure 27).
The pulsatile flow waveform exposed LECs to a 1-Hz waveform of -0.15-0.45 dyn/cm2
WSS and 8.64-12.30 cmH2O pressure with a mean pressure of 10.53 cmH2O. The steady
flow waveform exposed LECs to a constant WSS of [Need WSS Value for Steady Flow]
and a mean pressure of 10.68 cmH2O. Each pressure waveform was applied to LECs in
the absence of flow using the custom designed pulsatile pressure and a steady pressure
systems. The pulsatile pressure waveform generated a 1-Hz pressure waveform of
approximately 8.51-12.35 cmH2O with a mean value of 10.57 cmH2O. The steady
pressure waveform maintained a mean pressure of approximately 10.65 cmH2O. These
pressure values were in line with literature values for functionally relevant transmural
pressure measured in cannulated collecting lymphatics, which generally reach a
maximum systolic pressure range from 5.4 to 8.8 cmH2O75.
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Figure 27: Gauge Pressure Waveform for Each Experimental Conditions

3.3.2) Elevated Steady Pressure and Steady Flow Upregulated mRNA Expression of
Myosin Regulatory Light Chain Subunits MYL9 and MYL12B

LECS were exposed for 48 hours to atmospheric, elevated, and pulsatile pressure
conditions without flow, and steady and pulsatile flow conditions to determine the role of
transient mechanical stresses on MLC mRNA expression. As MLC is encoded by several
isoforms, the expression of MYL9, MYL12A, and MYL12B mRNA were quantified.
The mRNA expression of MYL9 and MYL12B mRNA were significantly upregulated in
response to steady pressure and steady flow compared to atmospheric pressure, pulsatile
flow, and pulsatile pressure (Figure 28). MYL12A was upregulated exclusively by
steady pressure compared to all other conditions.
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The mRNA expression of myosin heavy chains MYH9 and MYH10 was also
quantified, but no significant expression change was observed in response to any
condition. As
actin crosslinkers
contribute to
actomyosin
mediated cellular
stiffening,
mRNA
expression of the
actin crosslinker
FLNB was
examined. FLNB
is an isoform of
FLNA, which
was previously
shown to be
upregulated in
response to

Figure 28: In vitro LEC mRNA expression of FLNB, MYH10, MYH9,
MYL9, MYL12A, and MYL12B after exposure to each experimental
condition normalized by atmospheric pressure.

pressure in ECs 42. However, no FLNB mRNA expression change was measured in
response to any experimental condition. Taken together, these results suggest that
MYL12B and MYL9 are sensitive to steady pressure and flow but are not influenced by
the lower atmospheric steady pressure, pulsatile flow, or pulsatile pressure.
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3.3.3) Steady Pressure and Steady Flow Promote MLC Phosphorylation

The effect of atmospheric, elevated, and pulsatile pressure conditions without
flow, and steady and pulsatile flow conditions on MLC protein expression was also
tested. The total amount of MLC expression did not significantly change after exposure
to any condition (Figure 29). As increased MLC phosphorylation state is a hallmark of
endothelial hyperpermeability and inflammation, the single and double phosphorylation
states of MLC was assessed. The quantity of pMLC in LECs exposed to steady pressure
was significantly greater than in LECs exposed to atmospheric pressure, pulsatile
pressure, and pulsatile flow. Steady flow induced an increase in pMLC compared to
pulsatile pressure and atmospheric pressure. Following a similar trend, both steady
pressure and steady flow caused a significant increase in the quantity of LEC ppMLC
compared to atmospheric pressure, pulsatile pressure, and pulsatile flow. These data show
that steady elevated pressure and steady flow increase pMLC and ppMLC, suggesting a
contractile phenotype with increased permeability.
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Figure 29: In Vitro LEC Protein quantification of MLC, pMLC, and ppMLC after exposure to each
experimental condition normalized by atmospheric pressure.

3.3.4) Elevated Steady Pressure and Steady Flow Promote Phosphorylated MLC to
Colocalize with Peripheral Actin Network and Disrupt Barrier Function

Studies have reported that colocalization of phosphorylated MLC with the
peripheral actin network disrupts barrier function232. To determine whether mechanical
stresses modulate MLC phosphorylation and actin network formation in the cell
periphery, LECs were exposed to the five different experimental conditions (Figures 30 -
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33). Under exposure to atmospheric pressure, pMLC was observed in the perinuclear
cytoplasm consistent with reported findings (Figures 30 - 31)232. These cells were also
characterized by continuous VE-cadherin expression at the junctions. Consistent with
previous studies, the actin stain revealed prominent circumferential actin filaments, and
negligible stress fiber formation233 (Figure 31). ppMLC was sparsely distributed and
localized in the periphery (Figures 32 and 33). LECs exposed to pulsatile pressure
developed a small degree of central stress fiber formation (Figures 31 and 33). pMLC
colocalized in the cytoplasm with the central stress fibers, while ppMLC was sparsely
present in the periphery, similar to LECs exposed to atmospheric pressure. Colocalization
of pMLC and ppMLC with actin or VE-Cadherin was quantified using a Pearson
correlation coefficient and values are shown in Table 9.
LECs exposed to both steady elevated pressure and steady flow showed similar
morphological responses. Actin assembly was observed primarily in the peripheral cortex

Figure 30: Immunofluorescence analysis of pMLC and actin in LECs exposed to different pressure and
fluid flow profiles. Contrast was adjusted to emphasize localization and morphology.
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with minimal central stress fiber assembly. pMLC and ppMLC both colocalized with the
peripheral actin. LECs demonstrated discontinuous VE-cadherin junction expression and
exhibited intercellular gaps. The peripheral pMLC and ppMLC localization and gap
formation suggest a significant degree of cellular tension.
Similar to pulsatile pressure, pulsatile flow caused pMLC localization with central
actin stress fibers. ppMLC was observed in central stress fibers as well as peripheral
stress fibers. The continuous VE-cadherin junction expression did not suggest cellular

Figure 31: Immunofluorescence analysis of pMLC and VE-Cadherin in LECs exposed to different
pressure and fluid flow profiles. Arrows indicate endothelial gap formation. Contrast was adjusted to
emphasize localization and morphology.

tension or gap formation characteristic of a cytoskeletal tension driven permeability
increase. Therefore, steady elevated pressure and steady flow induced intercellular gap
formation, while pulsatile pressure and pulsatile flow did not exhibit intercellular gap
formation, suggesting that pulsatility protects LEC barrier function.
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3.3.5) Exposure of LECs to Steady Pressure, but not Pulsatile Pressure, Causes Barrier
Function Loss that is Rescued by MLCK Inhibitor ML-7
An in vitro transwell assay was used to determine the functional change of
permeability in LEC monolayers after exposure to 48 hours of atmospheric, elevated, and
pulsatile pressure conditions without flow (Figure 34). Steady elevated pressure induced
a significant increase in LEC permeability compared to both atmospheric pressure and
pulsatile pressure. LECs exposed to pulsatile pressure showed no change in permeability

Figure 32: Immunofluorescence analysis of ppMLC and VE-Cadherin in LECs exposed to different
pressure and fluid flow profiles. Arrows indicate endothelial gap formation. Contrast was adjusted to
emphasize localization and morphology.

compared to those exposed to atmospheric pressure. As increased EC permeability is
often the result of MLC phosphorylation via MLCK, each experimental condition was
simultaneously performed using the MLCK inhibitor ML-7. LECs treated with ML-7
exposed to atmospheric pressure, steady pressure, and pulsatile pressure showed no
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significant change in permeability. These data suggest that steady elevated pressure, but
not pulsatile pressure, caused increased permeability that is rescued by MLCK inhibition.

3.4) Discussion

3.4.1) Endothelial Cells can Discriminate Between Steady and Pulsatile Pressure

While the literature has well established that ECs respond to pressure, little is
known about the biological response of ECs to pressure exposure. As flow is inherently
driven by pressure gradients, cellular responses assumed to be WSS driven may be

Figure 33: Immunofluorescence analysis of ppMLC and actin in LECs exposed to different pressure and
fluid flow profiles. Contrast was adjusted to emphasize localization and morphology.

partially or entirely regulated by pressure. In this study, we designed custom pressure
systems to examine the response of LECs to physiologically relevant pressure waveforms
in the absence of flow. To the best of our knowledge, this is the first study to directly
compare the effects of exposing ECs in vitro to physiologically relevant pulsatile pressure
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and steady pressure of similar mean values. Our results suggest that not only do LECs
respond differently to pulsatile and steady pressure but that they respond differently even
at similar mean pressure values. Our findings are consistent with previous reports that
show increased EC increased permeability via MLC phosphorylation in response to
sustained pressure42,227. This permeability increase was rescued via MLCK inhibition,
suggesting that this pressure sensitive response was mediated in a MLCK dependent
manner. Interestingly, LECs exposed to pulsatile pressure of similar mean values
exhibited neither the permeability increase, increased MLC phosphorylation state, nor
exhibited intercellular gap formation observed in LECs exposed to steady pressure. These

Figure 34: Transwell permeability assay. LEC monolayers were exposed to a pressure
condition and permeability was measured via flux of FITC-labeled dextran and normalized
by atmospheric pressure. Each experimental condition was additionally performed using the
MLCK inhibitor ML-7.
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results suggest that steady pressure at physiologically relevant values promotes EC
barrier function disruption, while pulsatile pressure does not.
Exposure of LECs to either the steady pressure or steady flow condition caused
upregulation of MYL12B and MYL9 mRNA, suggesting that pressure, not WSS,
primarily influenced the mRNA upregulation. Additionally, the lack of mRNA
upregulation in response to pulsatile pressure suggests that the transcriptional regulatory
mechanisms can discriminate between steady and pulsatile pressure. MYL12A mRNA
was upregulated by steady pressure but not steady flow, suggesting that WSS and
Table 6: Antibodies used in immunofluorescence.
Phospho-

Primary

Rabbit

Cell

3674S

1:200

3675S

1:200

MAB9381

1:500

Novus

NBP1-

1:2000

Biologicals

72962

Invitrogen

A28175

Myosin Light

Signaling

Chain 2

Technology

(Thr18/Ser19)
Phospho-

Primary

Rabbit

Cell

Myosin Light

Signaling

Chain 2

Technology

(Ser19)
VE-Cadherin

Primary

Mouse

Novus
Biologicals

Anti-Rabbit

Secondary

Sheep

649
Anti-Mouse

Secondary

Goat

GFP
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pressure both influence expression. While the total amount of MLC protein did not
significantly change after exposure to any condition, mRNA expression does not
necessarily correlate to protein expression as translational regulatory mechanisms can be
complex.
The MLC phosphorylation state of LECs exposed to the different pressure and
flow conditions followed a similar trend. pMLC and ppMLC quantity were significantly
increased after exposure to steady pressure and steady flow, which often occurs in ECs in
response to inflammatory stimuli. This is in line with previous reports of increased MLC
phosphorylation in ECs exposed to steady pressure42,227. Pulsatile pressure and pulsatile
flow did not induce significant MLC phosphorylation, suggesting these conditions do not
promote a hyperpermeable EC phenotype.

3.4.2) WSS and Pressure Waveforms Induce Different LEC Phenotypes and Morphology

Another goal of this study was to examine the effect pressure and flow
have on LEC actomyosin dynamics and morphology via immunofluorescence. While
pMLC and ppMLC function and dynamics have been explored in ECs exposed to
inflammatory mediators such as thrombin, they have not been thoroughly examined in
Table 7: Antibodies used in western blotting.
Antibody Target

Type

Host

Vendor

Catalogue #

Species
Beta-Actin

Primary

Mouse

Dilution
Life
Technologies
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Working

AM4302

1:20,000
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Phospho-Myosin

Primary

Rabbit

Light Chain 2

Cell Signaling

3675S

1:200

3674S

1:200

SC-48414

1:1000

31430

1:5000

31460

1:5000

Technology

(Ser19)
Phospho-Myosin

Primary

Rabbit

Light Chain 2

Cell Signaling
Technology

(Thr18/Ser19)
Anti-

Primary

Mouse

MYL9/MYL12A/B
Anti-Mouse HRP

Santa Cruz
Biotechnology

Secondary

Goat

Thermo Fisher
Scientific

Anti-Rabbit HRP

Secondary

Goat

Thermo Fisher
Scientific

response to mechanical stimuli. MLC phosphorylation, localization, and actomyosin
stress fiber assembly play a complex role in mediating EC function. Exposure of ECs to
physiological flow generally induces stress fiber assembly, which may have a beneficial
effect on barrier function 234–236. However, excessive cytoskeletal tension via MLC
phosphorylation in ECs induces hyperpermeability237.
Our report shows that pulsatility pressure and pulsatile flow did not induce a
morphology associated with barrier function disruption, while both steady pressure and
steady flow showed VE-Cadherin disruption and gap formation. Pulsatile pressure
appeared to have a small effect on central stress fiber assembly, but the overall
morphology appeared comparable to LECs exposed to atmospheric pressure. Significant
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central stress fiber assembly was observed in LECs exposed to pulsatile flow, but the
continuous VE-cadherin lining suggests that this did not promote permeability.
Although our PPFC does not allow direct EC permeability measurements, the
disrupted VE-cadherin lining and intercellular gap formation in LECs exposed to 48
Table 8: Primers used in qRT-PCR.
Gene

Locus ID

Forward Primer (5’-3’)

Reverse Primer (3’-5’)

Fragm
ent
(bp)

GAP

NM_00204

TGTAGTTGAGGTCAA

ACATCGCTCAGACAC

DH

6.1

TGAAGGG

CATG

MYL

NM_18152

TGATGGCTTCATTGA

TCGTCCACTTCCTCA

126 or

9

6.1

CAAGGAG

TCTGT

288

MYH

NM_00247

CAAGACCGAGAAGAT CCACGTACGCCAGAT

9

3.1

CAATCCA

ACTG

MYH

NM_00125

CAGGGATGAGCAGA

CTTTGAAGCTACAGC

10

6012.3

ATGAAGA

AAGCG

MYL

NM_03354

CCTAACGCTCTTCGC

TTGGATGTTGCACGC

12B

6.1

TGTC

TGA

MYL

NM_00647

ATTTCACCATGTTCCT GCTCTCTCAAGTAAT

12A

1.1

CACCA

CTTCCTGT

FLNB

NM_00116

ACTTCGTGGTAGAAT

GTCGTTGTACTCAAT

4317.4

CCATTGG

CTTTGCC

82

143

97

112

144

132

89

DocuSign Envelope ID: E873C420-4555-4207-B475-B501A06C995D
6D8CBABF-A0E5-4AB6-B629-667997DBB115

hours of steady flow suggests barrier function compromise. The increase in pMLC and
ppMLC after exposure to this condition supports this conclusion. Only one study to our
knowledge has subjected LECs to WSS and examined its effect on permeability, and
found that barrier function increased after 30 minutes of exposure238. However, this does
not necessarily contradict our findings. Considering the short time scale of the
experiment, those observations do not necessarily translate to the response on LECs
following 48 hours of exposure to flow or pressure. Mechanical stimuli have been shown
to induce initial permeability changes that can return to baseline or even reverse
following long-term exposure. For instance, bovine aortic ECs show increased
permeability in response to steady flow after 1 hour in a cytoskeletal stiffness dependent
manner but return to baseline after 4 hours239. Another study found that gap formation
occurred in ECs after 8.5 hours of shear exposure240. Actomyosin mediated cellular
stiffening in ECs is a complex and time dependent mechanosensitive response that
requires.

3.4.3) Cellular Mechanisms of Pressure Sensing

Although the pressure values involved in this study are lower than the pressure
values in studies examining the response of blood ECs to pressure, LECs have been well
established to respond to mechanical stimuli an order of magnitude lower than blood
ECs27,28. Mesenteric collecting vessels have been shown to discriminate between pressure
changes between 1-9 cmH2O241,242.
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Demonstrating that LECs can discriminate between pulsatile and steady pressure
is not surprising as LECs respond differently to pulsatility in other mechanical stimuli.
For instance, lymphatic collecting vessel contraction occurs when LECs sense pulsatile
flow, but contractions are inhibited by steady flow even at similar mean WSS values 38.
Table 9: Pearson Correlation Coefficient for Immunofluorescence Co-staining of MLC
with Actin or VE-Cadherin.
MLC

Co-

Phosphorylation localizatio
State

n Target

pMLC

VE-

Atmospheric

Pulsatile

Steady

Steady

Pulsati

Pressure

Pressure

Pressure

Flow

le
Flow

-0.34

-0.124

0.034

0.138

-0.131

0.184

0.078

0.047

0.119

0.078

Cadherin
ppMLC

VECadherin

pMLC

Actin

0.35

0.675

0.867

0.828

0.867

ppMLC

Actin

0.389

0.587

0.821

0.791

0.349

This response is impaired when LECs are denuded, demonstrating that LECs are the
primary mechanosensors. Additionally, pulsatile stretch influences lymph vessel
orientation via lymphangiogenesis in LECs243.
Although previous studies have not directly compared the response of ECs to
pulsatile and steady pressure, other mechanosensitive cell types have demonstrated the
ability to discriminate between steady and pulsatile pressure. Osteocytes and
chondrocytes, which are mechanosensitive cell types with conserved mechanosensing
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mechanisms, have been thoroughly demonstrated to adopt phenotypic differences in
response to growing under pulsatile and steady pressure at similar mean values 40,41. Thus,
it is generally accepted that culturing chondrocytes under pulsatile pressure is favorable
to culturing them under steady or atmospheric pressure, possibly because it is more
similar to physiological joint load244. Similarly, steady pressure and steady flow are
generally not present in healthy lymphatic vessels and induced a dysfunctional LEC
phenotype.
The implications of the ability of ECs to discriminate between pulsatile and
steady pressure are not limited to lymphatics. The findings of this study emphasize a need
for more studies to elucidate the effect of subjecting other EC types to various pressure
waveforms. As the cardiovascular system experiences significant fluctuations in pressure
magnitude and waveform during physiological states like rest and exercise,
independently examining the effect of pressure could provide novel insight in EC
function. Notably, regarding pulmonary ECs, pulmonary hypertension has been reported
to be associated with pulmonary EC hyperpermeability245–247.
The mechanism by which ECs sense pressure stimuli remains incompletely
understood and requires further elucidation. Several studies have suggested that ion
channels such as ENaC may sense changes in pressure via ion flux42,227. Water efflux
through aquaporin 1 has also been demonstrated to be a pressure sensing mechanism in
ECs248. Considering the large number of putative mechanosensors involved in EC sensing
WSS, the cellular mechanism of pressure sensing may be similarly complex. Future work
is needed to elucidate how ECs can discriminate between pulsatile and steady pressure.
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3.4.4) Flow Characterization

This is the first study to our knowledge that has characterized lymphedema-like
flow in the collecting vessel of an animal model with dysfunctional valves. The vessel
with lymphedema-like flow demonstrated a high flowrate and the complete absence of
intrinsic lymphatic contractions. The intrinsic contractions of lymphatic collecting vessels
are inhibited in response to imposed flow, and that contractile frequency decrease linearly
as flow increases. Contractions will cease entirely if the flowrate is high enough,
presumably because they are unnecessary when lymph transport is already sufficient249.
However, without observing the vessel prior to contraction cessation, the cause of
contractile dysfunction cannot be definitively established. Additionally, intrinsic
contractile dysfunction is commonly reported in clinical lymphedema and remains poorly
understood250. Whether lymphatic pump dysfunction occurs before the development of
lymphedema or edematous conditions result in pump failure remains to be determined.

3.4.5) Clinical Implications

While the murine lymphedema model used in the present study retained a
considerable lymph flowrate, lymphedema is a highly varied and irregular condition.
Increased lymph flowrates have been reported in some cases of lymphedema, particularly
in the lower extremeties251. In many cases, lymph flow is slow, stagnant, or
retrograde252,253. The phenotype and morphology of LECs exposed to the steady pressure
condition may provide a relevant comparison to LECs in lymphedema vessels when
lymph flow is chronically stagnant. Considering the large degree of irregularity in terms
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of vessel geometry and flowrates in collecting vessels of a lymphedema patient, one
potentially has a spectrum of LEC phenotypes and morphologies. The findings of this
study emphasize the sensitivity of LEC morphology to changes in flow and pressure and
highlight the need for further examination of the mechanotransductive implications of
lymphedema.
Increased LEC hyperpermeability could potentially explain symptoms and clinical
complications in lymphedema patients. One obvious consequence of LEC
hyperpermeability is reduced lymph transport, as collecting permeability reduces the
lymph pressure gradient. In a state of increased LEC permeability, lymph exits the
collecting lymphatic lumen to interstitial space and must reenter initial lymphatics. As
lymph transport is an essential function of the lymphatic system, several lymphatic
functions are impaired when transport is impaired. Although lymphatic insufficiency is
already present in lymphedema cases, increased LEC permeability could exacerbate the
reduced lymph transport. The transport of antigens and antigen presenting cells to lymph
nodes is essential for the adaptive immune response to function. As lymphedema is
clinically associated with an impaired adaptive immune response, endothelial
hyperpermeability could potentially contribute to this symptom. When lymph transport is
impaired, antigens and leukocytes are inefficiently delivered to lymph nodes, which
weakens the adaptive immune response254. Additionally, lymphedema is a condition
characterized by chronic interstitial inflammation. A mouse demonstrated that induced
LEC hyperpermeability in mice causes inflammation in local tissue due to antigen
leakage51. Thus, increased LEC permeability could play a role in chronic inflammation
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that is described in clinical lymphedema patients. Regulation of permeability in collecting
vessels and its role in lymphatic function requires further study.
While the findings of this study need to be corroborated in vivo, these
observations suggest that MLCK may be a potential therapeutic target for patients with
lymphedema. Inhibition of MLCK has attracted interest in treating several vascular
conditions60. Interestingly, total deletion of MLCK in ECs of rats caused no observed
deleterious effects62. Despite this, due to the importance MLCK in numerous other cell
types, inhibition of MLCK is associated with significant side effects, so no MLCK
inhibitor has been approved for use in human patients. With future advances in targeted
drug delivery, specific delivery of an MLCK inhibitor to LECs may be a potential
therapy in lymphedema patients.

4.) Conclusion and Future Work
4.1) Summary and Conclusion

While mechanotransduction in blood vessels has been thoroughly examined, Fluid
flow in a murine collecting lymphatic vessel was characterized via fluorescent
microparticles injection into the inguinal lymph node. Flow waveforms were
characterized in the midlymphangion region of the lymphangion and the valvular sinus.
The flow waveform in the midlymphangion region was found to be pulsatile netantegrade flow with a small amount of retrograde flow, while flow in the valvular sinus
was virtually static. The resulting flow waveforms were applied to LECs in vitro to
elucidate effects on LECs via mechanotransduction. The resulting mRNA and protein
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expression changes were quantified via RT-qPCR and western blotting, respectively. Cell
adhesion molecules ICAM-1, ICAM-2, JAMA, and LYVE-1, which play a role in
leukocyte and CTC extravasation, were quantified. mRNA and protein of all cell
adhesion molecules were upregulated in all genes in LECs exposed to static conditions
compared to the midlympangion waveform. Additionally, the mRNA expression of the
leukocyte and CTC attracting chemokines CCL2, CXCL2, and IL-8 were also quantified
and found to be expressed more in LECs exposed to static conditions compared to the
midlymphangion waveform. These in vitro results suggest that these cell adhesion
molecules and chemokines may be upregulated in the lymphangion sinus compared to the
rest of the vessel, promoting a pro-inflammatory niche. Furthermore, the static flow
conditions would increase the residence time of secreted molecules, promoting
chemokine accumulation. These factors would make leukocyte transmigration more
favorable in the sinus, suggesting that this region may play an important role in leukocyte
trafficking and transport. Additionally, few studies have examined the mechanism of intransit metastasis, which results from CTC extravasation in lymphatic collecting vessels.
The sinus may provide a preferable microenvironment for cancers, such as melanoma, to
extravasate and form secondary tumors.
Additionally, as lymphedema greatly alters lymph flow, the flow profile in a
lymphedema-like vessel may be significantly influencing LEC phenotype via
mechanotransduction. As lymphedema generally results from valve incompetence, flow
was measured in a CLEC-2 deficient mouse, which does not develop lymphatic valves.
Flow was observed to have a steady unidirectional antegrade profile. Additionally,
pressure is known to influence mechanotransduction but has been relatively
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underexamined compared to WSS. As fluid flow is inherently driven by pressure
gradients, mechanosensitive responses attributed to WSS may be partially or entirely the
result of pressure. To isolate pressure as a variable, steady and pulsatile pressure systems
were developed to apply the lymphedema-like and midlympangion pressure waveforms
to LECs in the absence of flow. As steady pressure has been previously shown to
influence actomyosin dynamics in ECs, expression of myosin genes and myosin
phosphorylation state were quantified. mRNA expression of MYL9 and MYL12B were
found to be upregulated both by steady pressure and steady flow, but not pulsatile
pressure and pulsatile flow of similar mean pressure values. Protein analysis showed that
the protein expression of myosin light chain did not increase under exposure to any
condition. The upregulation of mRNAs suggests transcriptional regulatory mechanisms
that are sensitive to pressure and pulsatility. Additionally, quantities of pMLC and
ppMLC were examined as each are involved in actomyosin contractility and associated
with endothelial inflammation and hyperpermeability. Both pMLC and ppMLC were
present in higher quantities in LECs exposed to steady pressure and steady flow
compared to pulsatile pressure and pulsatile flow. Immunofluorescence analysis revealed
intercellular gap formation in LEC monolayers exposed to steady pressure and steady
flow but not when exposed to other conditions. Additionally, permeability was
significantly increased in LEC monolayers exposed to steady pressure compared to
pulsatile flow, but that this permeability increase was rescued via MLCK inhibitor ML-7.
These results suggest that steady pressure and steady flow induce LEC
hyperpermeability. Increased permeability in collecting vessel LEC promotes lymph and
antigen leakage that has several deleterious effects, such as reducing lymph transport,
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impairing the adaptive immune response, and causing inflammation of local tissue. To
our knowledge, this study is the first that has compared the effects of exposing ECs to
pulsatile and steady pressure of similar mean values.

4.2) Future Work
While the lymphatic system has been historically viewed as a passive system,
contemporary perspectives are increasingly recognizing that the lymphatic system plays
an active and adaptive role in leukocyte trafficking and antigen transport. The response of
LECs to different physiologically relevant flow waveforms certainly requires further
examination. Apart from molecules that enable leukocyte transmigration, other important
genes and pathways are likely activated under certain flow conditions. Additionally, the
in vitro findings of this study need to be validated in vivo. Furthermore, lymphatic
vessels have highly variable geometry and flowrates, even within the same animal.
Lymph flow profiles in more animal models need to be characterized. While collecting
vessels are of similar size between mammalian species, characterizing flow in human
collecting vessels would be ideal. However, due to the inherent difficulties in examining
lymphatic vessels, no ethical way exists to characterize flow waveforms in a human
lymphatic vessel to the degree of accuracy presented in this study.
LECs adopting a hyperpermeable state via actomyosin contractility in response to
sustained pressure is a discovery that could potentially lead to improved treatment of
clinical lymphedema. Increased LEC permeability in collecting vessels could potentially
exacerbate symptoms associated with lymphedema such as impaired lymph transport,

91

DocuSign Envelope ID: E873C420-4555-4207-B475-B501A06C995D
6D8CBABF-A0E5-4AB6-B629-667997DBB115

adaptive immunity, and chronic inflammation. Examining the effects of inhibiting
actomyosin contractility in a lymphedema model would be an interesting experiment.
Discovering that ECs can discriminate between steady and pulsatile pressure of
similar mean values likely has important implications in blood and pulmonary ECs. As
lymphedema is analogous to arterial hypertension, activation of certain genes in ECs may
be conserved between the two conditions. Similar experiments should be conducted using
blood ECs at physiologically relevant blood pressure values to further elucidate the role
of pressure in blood EC mechanosensing. Such experiments could increase understanding
of the basic mechanisms of EC mechanosensing provide insight that may improve
clinical care.
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Appendix

Appendix Figure 1: Labview block diagram of pulsatile pressure system.

Appendix Figure 2: Labview block diagram of steady pressure system.
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